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 ABSTRACT  
 
Perseveration and health: An experimental examination of worry and relaxation on autonomic, 
endocrine, and immunological processes 
 
Megan Elizabeth Renna 
 
The field of psychoneuroimmunology seeks to examine the impact of stress and other 
psychological processes on physical health. While some theories suggest that processes such as 
worry may have a significant impact on prolonging the physiological stress response and 
subsequently increasing risk for long-term health issues, to date, this research has not yet 
thoroughly examined the impact of worry on physical health processes. The current study sought 
to combine theories from clinical and health psychology to investigate the impact of 
experimentally-induced worry and relaxation on cortisol, heart rate variability (HRV), and 
inflammation. Participants (N = 85) were community members from the New York City area. 
They completed worry and relaxation inductions within the laboratory while HRV was collected 
continuously. Three blood samples were taken throughout the study to test for inflammation and 
cortisol. Results indicated changes in HRV, IL-6, and IFN-γ throughout the study conditions that 
were not moderated by levels of trait worry. HRV, cortisol, and inflammation did not covary 
throughout the different experimental conditions and changes in cortisol and/or HRV did not 
temporally precede changes in inflammation throughout the study. Overall, the findings from the 
current study offer insight into the contrasting impact that worry and relaxation have on 
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Psychoneuroimmunology and anxiety 
Over the past several decades, the field of psychoneuroimmunology (PNI) has emerged 
in an effort to understand the impact that psychological processes have on immune and nervous 
system activities. The primary goal of the immune system is to fight against infectious or 
otherwise harmful agents within the body that threaten overall healthy functioning (Sapolsky, 
1994). PNI research and theory have demonstrated a link between negative emotions (i.e., 
anxiety, fear, sadness, anger) and dysregulated immune system functioning, which may cause 
infection, inflammation, and an overall increased risk for experiencing a wide variety of chronic 
health issues (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002). The interaction between stress 
and/or negative emotions and autonomic, endocrine, and immune processes is at the nexus of this 
field of study and has contributed to a growing body of research linking subjective emotional and 
cognitive experiences and physical health.  
Part of the theory guiding PNI research underscores the importance of subjective 
experiences of stress on the body, as stress leads to inhibition of immunological processes and 
therefore inhibits the necessary fight against infectious agents within the body. Anxiety, defined 
as a feeling of nervousness or worry about a real or uncertain potential threat either in the current 
moment or the future, is a prime emotion to better understand the links between physiological 
processes in the body and the impact that these subjective emotional experiences have on them. 
Anxiety disorders represent chronic, excessive, and severe anxiety as part of their diagnostic 
criteria (American Psychiatric Association, 2013) – i.e. a dysregulated experience of anxiety that 
is often more severe and debilitating in nature than more normative and briefer states of anxiety. 
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Although anxiety disorders are categorically distinct, they share a number of common 
characteristics. Among these, individuals suffering from anxiety experience distorted thinking 
(Turner, Beidel, & Stanley, 1992; Cox, 1996; Falsetti, Monnier, Davis, & Resnick, 2002), greater 
emotion dysregulation (Mennin, Heimberg, Turk, & Fresco, 2005; Weiss, Tull, Anestis, & Gratz, 
2013) and engage in experiential avoidance of anxiety-inducing stimuli (either real or perceived; 
Hayes, Wilson, & Gifford, 2015), subsequently putting them at an increased risk for overall 
psychological and physiological dysregulation compared to their psychologically healthy 
counterparts. Research has also demonstrated that individuals with anxiety disorders are 
hypersensitive to contextual cues that may contribute to or maintain anxiety, thus leading to an 
increased likelihood of experiencing prolonged and/or more frequent physiological activation. 
PNI research has begun to examine the impact of anxiety on overall health, highlighting that the 
links between overall psychological and physiological dysregulation (Kemp & Quintana, 2013).      
Physiological dysregulation is a criterion for diagnosis in a number of different anxiety 
disorders (i.e. muscle tension in generalized anxiety disorder, hypervigilance in post-traumatic 
stress disorder, and numerous physical symptoms such as rapid heartbeat, sweating, and 
difficulty breathing in panic disorder; American Psychiatric Association, 2013). The physical 
symptoms associated with an anxiety disorder diagnosis represent the necessity of understanding 
the long-term physical ramifications of anxiety on an individual’s physiological and 
immunological processes. Taken together, the field of PNI presents an important and necessary 
perspective in understanding the ways that subjective processes at the person-level may impact 
overall health and wellbeing. When the body is in a state of prolonged physiological activation, 
there is a substantially increased risk for an individual to experience systemic, chronic negative 
health implications. One of the most widely studied systems implicated during times of 
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prolonged physiological activation is the HPA axis, a neuroendocrine system comprised of the 
hypothalamus, pituitary gland, and adrenal glands. The HPA axis is involved in adaptations to 
stress and change. It is also responsible for the regulation of several other processes such as 
digestion, the immune system, the cardiovascular system, the reproductive system, as well as 
contributing to fluctuations in mood and emotions. Given the central role that the HPA axis plays 
in physiological dysregulation, it is important to understand both the physical and psychological 
mechanisms that may link activation of this system to poor health outcomes in the long term 
(Tsigos & Chrousos, 1994).  
While a number of psychological processes associated with these disorders may impact 
physical health, much of the current research examining subjective experiences within people 
with anxiety has been worry. Worry, a characteristic of generalized anxiety disorder (GAD) and 
common across several other forms of psychopathology, is best defined as thinking repeatedly 
about things in the future (Borkovec, Robinson, Pruzinsky, & DePree, 1983). The triparate 
function of worry suggests this cognitive process helps to alarm individuals to potential threats, 
prompts awareness to unresolved threatening situations, and, lastly, prepares individuals for a 
necessary ‘fight or flight’ response (Frijda 1988; Lazarus 1991). Therefore, when worrying, 
individuals are in an apprehensive state of anticipation of real or perceived subjective threats in 
the environment, which causes wear and tear on the body over the long term. Despite the 
objective complications associated with worry both at the emotional and somatic levels, worry 
may subjectively serve an adaptive and positive function for some individuals, as theoretical 
understandings of worry have suggested that it is an attempt to prevent negative experiences 
from occurring or to prepare oneself for the presence of negative experiences (Borkovec 1994; 
Borkovec 2004). The Contrast Avoidance Model, a theory developed to help explain the utility 
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of worry and highlights the importance of the maintenance of worry as an adaptive mechanism 
for reducing the unpleasantness of emotional shifts from positive to negative (Newman & Llera, 
2011). According to this theory, worry does not lead to the avoidance of negative emotions. 
Rather, it sustains negative states once they have already developed.  
To date, there have been a number of studies within the worry literature that have begun 
to test the Contrast Avoidance Model through examining subjective and physiological 
differences between worry and relaxation conditions among worriers and non-worriers. Indeed, a 
2010 study of people with GAD (i.e., high worriers) compared to nonanxious controls 
demonstrated that those with GAD reported that their worry helped them to cope while viewing 
emotional film clips, while the reverse was true for the nonanxious group (Llera & Newman, 
2010). Most recently, a 2013 study examined the impact of worry and relaxation among low trait 
worriers, high trait worriers who did not meet diagnostic criteria for GAD, and people diagnosed 
with GAD. Participants in all groups were randomized to receive either the worry or relaxation 
condition. Results demonstrated a significant effect of condition, in that individuals in all three 
groups reported significant increases in subjective ratings of worry from pre-worry to post-worry 
(Fisher & Newman, 2013). Subjective findings within the relaxation condition demonstrated a 
significant increase in relaxation from pre- to post-manipulation regardless of group. However, 
post-hoc analyses found that there were only significant differences between people with GAD 
and controls in subjective ratings of relaxation, indicating no differences between the GAD and 
high worry group or the high worry group and controls (Fisher & Newman, 2013). There have 
been a number of studies that have utilized a similar task design and demonstrated subjective 
differences in worry throughout the worry manipulation compared to baseline among individuals 
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with and without diagnoses of GAD compared to healthy controls (Llera & Newman, 2010; 
Borkovec & Inz, 1990; Oathes, Ray, Yamasaki, Borkovec, Castonguay, & Newman, 2008).  
These studies have also examined the role of relaxation between these groups with 
varying instructions from more imagery-focused relaxation tasks to instructions that encourage 
participants to engage in several variations of deep-breathing exercises. A number of these 
studies’ findings were replicated by Fisher & Newman’s recent work but largely focused on 
people with GAD compared to healthy controls, and therefore failed to consider the important 
impact that trait worry, broadly, may have on maintaining negative emotions even when 
instructed to relax. These findings have generally demonstrated greater subjective levels of 
relaxation regardless of group (i.e., Borkovec & Inz, 1990; Llera & Newman, 2010); however, in 
the majority of these studies, participants were randomized to receive either worry or relaxation, 
rather than both conditions, thus not permitting the ability to fully examine Contrast Avoidance 
by assessing whether or not participants are able to subjectively and/or physiologically recover 
from the impact of worry through the utilization of relaxation strategies. Taken together, this 
theory and associated findings highlights the functionally sustaining nature of worry for some 
individuals, and this constant state of cognitive activation may have deleterious implications on 
physical health given what is known about anxiety in dysregulating autonomic and endocrine 
processes in the body. 
The Perseverative Cognition Hypothesis 
Given that many anxiety disorders are characterized by high degrees of perseverative 
processes such as worry and rumination (i.e., thinking back over past losses and failures; Nolen-
Hoeksema, Wisco, & Lyubomirsky, 2008), these processes may contribute to physiological 
dysregulation independent of a formal psychological diagnosis. However, many studies 
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examining stress and coping have largely failed to examine the impact of worry and rumination 
in exacerbating or maintaining somatic health complaints and long-term deleterious health 
outcomes. In an effort to better capture and understand the role that these processes may play in 
the context of health, the perseverative cognition hypothesis (PCH) was developed as a way to 
better conceptualize these relationships. The central theory of the PCH links increases in 
cognitive activation such as worry with negative physical health outcomes. The development of 
this theory and the body of research associated with it highlights the potential long-term 
implications of cognitive processes associated with anxiety and depression on physical health 
and may highlight potential cognitive mechanisms that may link anxiety to increases to overall 
poor health.  
According to the PCH, sustained cognitive activation such as that consistent with 
chronically worrying or ruminating, may contribute to increased endocrine, immune, and 
autonomic reactivity, subsequently putting these individuals at an increased risk for experiencing 
deleterious health effects (Brosschot, Gerin, & Thayer, 2006). Specifically, this theory takes into 
account the cognitive processes that may precede or come after stressors – highlighting the fact 
that a stressor in and of itself may not be the most physiologically activating thing in a chain of 
events for those who are high in perseveration. Essentially, perseveration prolongs a 
physiological stress response, putting individuals in a chronic state of physiological arousal and 
subsequently at greater risk for experiencing negative health outcomes (Brosschot et. al, 2006).  
Traditional theories of stress and adaptation have conceptualized coping strategies as a 
means of recovering from stressors and returning to homeostasis. Within this framework, coping 
serves as a moderator between stress and subsequent health outcomes (Brosschot et al., 2006). In 
contrast, perseverative cognition is considered a mediator between stress and health, in that these 
IMMUNOLOGICAL AND PHYSIOLOGICAL IMPACT OF WORRY 
7 
 
cognitive processes tend to prolong the stress experience and prohibit the ability for the body to 
recover physiologically (i.e., putting individuals in constant ‘fight or flight’ preparation). 
Therefore, although researchers have established the link between anxiety and chronic health 
conditions, these perseverative processes may serve as mediators of this relationship. However, it 
is necessary to first better understand the impact that these processes may have on physical 
processes that may contribute to poor health, including inflammation, cortisol, and cardiac 
dysregulation. By clarifying the impact of these processes on these more general markers of 
physical health, researchers may be better able to determine the potential targets for improving 
both physical and psychological intervention.  
The PCH also builds upon foundational avoidance theories of worry (Borkovec 1994; 
Borkovec 2004), which emphasize one function of worry as a way to mute somatic responses to 
threat. A number of studies have shown that worry is associated with greater physiological 
activation broadly compared to relaxation or neutral conditions (Borkovec & Hu, 1990; 
Borkovec, Robinson, Pruzinsky, & DePree, 1983). Preliminary research findings in support of 
the PCH have demonstrated an impact of worry and relaxation on blood pressure, cortisol, heart 
rate variability (HRV), and immune markers with clear associations between cognitive and 
physiological variables and some emerging evidence of casual predictions between the two 
(Ottaviani et al., 2016). These findings are outlined below and highlight a small, but important 
body of literature that promotes a first step in disentangling this complex relationship. 
Inflammation 
One of most prominent and widely studied markers of immune functioning and overall 
physical dysregulation is inflammation, which can be characterized as either acute or chronic. An 
acute inflammatory response is activated when the body suffers illness or injury, where cytokines 
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or related proteins are triggered to the affected area in the periphery, promoting the healing 
process. In an adaptive acute inflammatory response, following repair, these proteins retreat, and 
the body returns to a state of homeostasis (Ryan & Majno, 1977). This immunological process, 
however, becomes dysregulated when in a chronic state of autonomic or immunological 
activation. This constant state of physiological activation subsequently may put an individual at 
increased risk for experiencing chronic inflammation. Chronic inflammation is a process where 
the body becomes unable to shut off its inflammatory response leading to a high level of 
inflammation. In the absence of acute illness or injury, circulating proteins begin to attack 
healthy tissue. The HPA axis provides bi-directional communication with the immune system, 
which subsequently leads to the release or inhibition of inflammatory cytokines. The interaction 
of these systems is important given that dysregulation of either the HPA axis or the immune 
system can contribute to an increased likelihood of experiencing chronic inflammation.  
Although chronic inflammation can be measured via a number of different 
immunological markers, cytokines tend to be the most frequently used metric in the majority of 
clinical research, particularly within clinical and health psychology. Cytokines are a specific type 
of protein, typically characterized as a chemokine, interferon, interleukin, or tumor necrosis 
factor that circulates spontaneously in the blood. These specific proteins are derived from a 
number of different cells (i.e., macrophages, lymphocytes, and mast cells). Cytokines may have 
pro-inflammatory properties (i.e., IL-1β, IL-2, TNF- α, IFN- γ), which promote higher rates of 
inflammation within the body, or anti-inflammatory (i.e., IL-4, IL-8, IL-12), whose release 
promotes the reduction of inflammation within the body. Additionally, interleukin-6 (IL-6) has 
both pro- and anti-inflammatory properties. Within psychological research, IL-6 is largely 
considered to be a pro-inflammatory cytokine, promoting the presence of inflammation in the 
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body. Although each of these proteins are derived from different types of cells, they all lead to 
immunological changes within the body that, over time, can have a significant impact on health 
and overall physiological functioning. 
Increased rates of pro-inflammatory cytokines are associated with a number of 
deleterious health outcomes. Higher and prolonged levels of such markers contributes to a higher 
likelihood of experiencing congestive heart disease (Kaptoge et al 2013), inflammatory bowel 
disease (Halpin & Ford, 2012), Alzheimer’s disease (Swardfager, Lanctôt, Rothenburg, Wong, 
Cappell, & Herrmann, 2010), chronic obstructive pulmonary disease (Gan., Man, Senthilselvan, 
& Sin, 2004), cancer (Heikkilä et. al, 2009), and stroke (Kuo, Yen, Chang, Kuo, Chen, & 
Sorond, 2005). Although these findings are largely correlational, the vastness of the literature 
examining the relationship between chronic inflammation and physical diseases highlights the 
need to better understand physical and psychological risk factors for high rates of inflammation 
in an effort to better prevent these long-term chronic health issues. Within coronary heart 
disease, a meta-analysis of prospective studies demonstrated higher levels of c-reactive protein 
(CRP), a protein circulating in the body that is produced as a direct result of higher levels of 
inflammation, being prospectively associated with development of the disease (Danesh et. al, 
2000). Generally, high levels of inflammation are often a risk factor for metabolic syndrome, a 
non-specific condition diagnosed by assessing the presence of higher than average levels of 
triglycerides and/or fasting glucose, lower than average levels of HDL cholesterol, high blood 
pressure, and obesity. Metabolic syndrome is associated with heart disease, stroke, diabetes, and 
mortality broadly (Kaur 2014). As stated above, the HPA axis contributes to the regulation of the 
immune system, and the increase of inflammatory cytokines may therefore suggest a potential 
mediator in HPA axis dysregulation and these negative health outcomes.  
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Given the numerous negative health implications of high levels of pro-inflammatory 
cytokines, scientists and researchers have become increasing interested in understanding the link 
between inflammation and physical health. In addition, there has been an increasing amount of 
research and media coverage that have documented different methods for reducing inflammation, 
including specific diets, over the counter and prescription medications and lifestyle changes 
(including alterations in smoking, alcohol consumption, exercise, etc.). Although inflammation 
has been examined more widely within health psychology in relation to acute and chronic stress, 
clinical psychology has begun examining these variables and their relation to psychological traits 
and symptoms more and more over the past two decades.  
Anxiety disorders have been shown to lead to increases in a number of inflammatory 
conditions such as inflammatory bowel disease, rheumatoid arthritis, and asthma (O’Donovan et. 
al, 2010). Patients with chronic obstructive pulmonary disease (COPD) have 5.3 times higher 
rates of anxiety disorders than a physically healthy comparison group (Karajgi, Rifkin, Doddi, & 
Kolli, 1990). Further, research examining anxiety disorders within patients with inflammatory 
bowel disease (IBD) found that rates of GAD, panic disorder (PD), and obsessive-compulsive 
disorder (OCD) were higher in patients with IBD than in general community samples of 
physically healthy individuals (Walker et. al, 2008). Within people with coronary heart disease 
(CHD) prevalence rates of SAD and GAD have shown to be 21.3% and 18.7%, respectively, 
with both of these rates substantially higher than in psychologically healthy individuals (Todaro, 
Shen, Raffa, Tilkemeier, & Niaura, 2007). This highlights the integral role that anxiety plays in 
physical health. However, to date, similar to the issues in examining inflammation and physical 
health, it is difficult to disentangle this relationship to determine whether anxiety causes an 
increased likelihood for experiencing these health conditions, or, rather, if these illnesses 
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increase the likelihood of feeling anxious. This remains a theoretical and empirical question 
within the field of psychoneuroimmunology. Given these demonstrated links of anxiety and 
inflammation with numerous physical health conditions, it is important to elucidate the ways in 
which these immunological and psychological processes may interact with one another.  
There has been a large amount of research that has examined the relationship between 
depression and inflammation over the past several decades. A 2010 meta-analysis synthesizing 
these results highlighted a significant difference between individuals with a depression diagnosis 
and healthy controls, but only within a limited number of inflammatory markers (i.e., IL-6 and 
TNF-α; Dowlati et. al, 2010). In terms of anxiety, a number of studies have examined the 
relationship between anxiety symptoms broadly and inflammation (Duivis, Vogelzangs, Kupper, 
de Jonge, & Penninx, 2013; Pitsavos, Panagiotakos, Papageorgiou, Tsetsekou, Soldatos, & 
Stefanadis, 2006) as well as the physiological impact of chronic stress (McEwen, 2004; Miller, 
Chen, & Zhou, 2007). An anxiety diagnosis, however, is highly relevant to understanding 
inflammatory dysregulation, as it is characterized by a chronic state of preparation and defense to 
possible threats and may, therefore, put the body at potential risk for negative health effects from 
this more or less constant state of heightened physiological arousal. These disorders in particular 
represent an essential avenue for future research, as immune functioning may be more 
dysregulated in people with anxiety disorders than those simply high general state anxiety 
symptoms, which tend to be relatively non-specific. Therefore, measures of trait anxiety may not 
be specific enough to detect psychological mechanisms that underlie the link to exacerbated 
inflammatory cytokines.  
Emerging research over the past several decades has provided some preliminary evidence 
for the impact of a diagnosis of an anxiety disorder on inflammatory biomarkers, but the majority 
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of this research has been conducted within PTSD and OCD with little consensus on the impact of 
diagnosis on inflammatory markers. A 2009 systematic review of PTSD and chronic 
inflammation indicated that individuals with PTSD have significantly higher levels of 
inflammatory dysregulation in comparison to healthy controls (Gill, Saligan, Woods, & Page, 
2009). Researchers recently published an updated meta-analysis examining levels of different 
cytokines among individuals with PTSD and healthy controls. These findings demonstrated 
significantly higher levels of IL-6, IFN- γ, and IL-1β in people with PTSD compared to healthy 
controls (Passos et al., 2015). Within OCD research examining inflammation, a 2012 systematic 
review and meta-analysis showed that there were no significant differences in IL-6 or TNF-α 
between people with OCD and healthy controls (Gray & Bloch, 2012). However, there was a 
significant difference in IL-1β between the two groups. These results differed between 
individuals who had a comorbid depression diagnosis versus no depression comorbidity and 
among adults and children, as this meta-analysis included both age groups (Gray et. al, 2012), 
highlighting an important role that depression may play in understanding the link between 
anxiety disorders and inflammation. Further, across other anxiety disorders (i.e., generalized 
anxiety disorder, social anxiety disorder, and panic disorder), the evidence has generally been 
sparse and somewhat mixed (Furtado & Katzman, 2015). A recent meta-analysis found an 
overall significant difference between physically healthy adults with anxiety, obsessive-
compulsive, and traumatic stress disorders and healthy controls in terms of pro-, but not anti-
inflammatory markers (Renna, O’Toole, Spaeth, Lekander, & Mennin, 2018). In terms of 
breakdown between specific diagnostic groups, we found that those with PTSD had significantly 
different levels of pro-inflammatory cytokines compared to controls but that those with other 
anxiety disorders, including PD, GAD, SAD, and OCD did not. However, the majority of the 
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research linking anxiety disorders and inflammatory cytokines were within PTSD and the study 
was therefore underpowered to detect these between-group differences. Additionally, contrary to 
findings of other meta-analytic investigations, co-morbid depression did not moderate these 
results (Renna et al., 2018). Taken together, these findings indicate an overall significant impact 
that anxiety may have on inflammatory functioning. The findings from both depression and 
anxiety disorders research have demonstrated that some, but not all, of the inflammatory markers 
tested differ between people with psychopathology and healthy controls. Currently, the field of 
psychology has not yet disentangled why this may the case – however, it may be that these 
psychological processes impact the different cells that produce these cytokines differently, which 
in turn promotes greater dysregulation in some systems (i.e., macrophages that produce TNF- α, 
IL-6, and a number of other cytokines in the interleukin family). However, to date, no studies 
have examined mechanisms that may have impacted this relationship and future research is well 
geared to begin to disentangle how anxiety may influence inflammation and vice versa. 
According to the PCH, it may be hypothesized that cognitive processes such as worry and 
rumination may underlie the link between anxiety and high levels of pro-inflammatory 
cytokines. 
Heart Rate Variability 
Although research examining the long-term negative health impact of perseverative 
cognition is sparse in terms of its relationship to inflammatory processes, empirical examinations 
of the PCH as well as worry and rumination more broadly have demonstrated considerable 
evidence to support this theory. Perseverative cognition impacts the autonomic nervous system 
(ANS), comprised of the excitatory sympathetic nervous system (SNS) and the inhibitory 
parasympathetic nervous system (PNS). The body’s ability to rapidly shift between excitatory 
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and inhibitory states demonstrates flexibility in heart rate. To date, research examining the 
physiological implications of perseveration has largely focused on autonomic measures such as 
heart rate variability (HRV). HRV is considered to be a marker of shifts between the SNS and 
PNS, with several metrics of HRV focusing on this autonomic balance while others are 
considered to be a putative measure of PNS responding (Allen, Chambers, & Towers, 2007). 
These putative measures of PNS responding are those most closely linked to psychopathology 
and particularly anxiety disorders (Applehans & Leuken, 2006). HRV is traditionally measured 
by the variation in beat-to-beat intervals of the heart that is thought of as a proxy for emotional 
responding (Applehans & Leuken, 2006). Higher HRV is largely considered to be more adaptive, 
as it demonstrates greater autonomic flexibility. Indeed, persistently low HRV is associated with 
higher risk for cardiovascular disease (i.e., congestive heart failure, stroke, hypertension, heart 
failure) as well as poor outcomes as a result of these conditions (Stauss 2003). 
Autonomic processes such as HRV have been widely studied in relation to perseverative 
cognition. Previous research has demonstrated that individuals higher in trait worry are more 
likely to experience lower baseline HRV (i.e., greater cardiac rigidity) compared to those less 
prone to worrying (Lyonfields, Borkovec, & Thayer, 1995; Thayer, Friedman, & Borkovec, 
1996; Brosschot, Van Dijik, & Thayer, 2007). In response to an experimental stressor task, high 
trait worriers also demonstrated slower HRV recovery (i.e., shifting from lower HRV during the 
task and returning to baseline HRV after the task) compared to low trait worriers (Verkuil, 
Brosschot, Beurs, & Thayer, 2009). Further, in comparing rates of HRV during state-level 
subjective rates of worry and rumination in response to emotion-eliciting film clips among 
physically and psychologically healthy participants, research has shown that worry is more 
closely associated with HRV than rumination (Aldao, Mennin, & McLaughlin, 2013). Taken 
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together, these findings highlight the integral role that worry plays in promoting autonomic 
dysregulation, subsequently putting individuals at risk for negative cardiovascular outcomes in 
the long-term. 
Examinations of perseverative cognition in healthy participants have demonstrated 
similar findings to those utilizing high and low trait worry samples. Among psychologically 
healthy undergraduate students, those instructed to worry, compared to those instructed to relax 
or those given a neutral mentation condition had significantly lower vagal activity throughout the 
experiment (Llera & Newman, 2010). Independent of experimental manipulation, research 
findings indicate that when HRV is measured among physically healthy men and women, those 
who reported greater emotional stress during the week prior to study participation had lower 
levels of resting HRV compared to those who reported low levels of emotional stress (Dishman, 
Nakamura, Garcia, Thompson, Dunn, & Blair, 2000). A recent meta-analysis examining the 
impact of perseverative cognition (defined as either worry or rumination, either at the state or 
trait level) on HRV and other health-related processes found a significant decrease in HRV 
throughout experimental manipulations of perseverative in individuals free of psychological or 
physical diagnoses. Among correlational studies, there was also a significant association between 
higher levels of perseverative cognition and decreased HRV (Ottaviani, Verkuil, Medea, 
Couyoumdjian, Thayer, Lonigro, & Brosschot, 2016). Taken together, these findings highlight 
that worry, independent of psychopathology, contributes to significantly lower HRV compared 
to low levels of worry and compared to experimental conditions aimed at promoting relaxation 
or rumination. These findings are significant as they suggest not only simple baseline 
relationships between these variables but a possible more mechanistic role that perseverative 
cognition may play in exacerbating HRV dysregulation independent of chronic and excessive 
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rates of these cognitive processes common to GAD and MDD. It is therefore imperative to better 
understand the autonomic and immunological impact of worry on worsened physical health. 
HRV also tends to be lower among people with formal diagnoses of anxiety disorders 
compared to healthy controls, and this comparison is especially salient for disorders 
characterized mainly or in part by worry. Compared to healthy controls, a 2014 meta-analysis 
found that people diagnosed with GAD, PTSD, SAD, and PD, but not OCD, had significantly 
lower HRV (Chalmers, Quintana, Abbott, & Kemp, 2014). These findings highlight the integral 
role that anxiety processes may have on autonomic functioning but fail to demonstrate whether 
there are mechanisms underlying the link between an anxiety disorder diagnosis and lower HRV. 
Further, it remains unclear whether decreased HRV may contribute to further negative health 
implications, such as higher rates of pro-inflammatory cytokines.  
Cortisol 
In addition to autonomic outcomes used to assess the PCH, cortisol has been used 
frequently in relation to both experimental inductions of perseverative cognition and trait level 
perseverative cognition. Cortisol is a hormone that is produced via the adrenal gland, often in 
response to stress, and therefore serves as a potent marker for HPA activation and has 
subsequently been widely used to understand the impact of stress on the body. Specifically, 
cortisol is released by the adrenal gland in times of increased stress, which subsequently 
contributes to a cascade of immunological and autonomic changes in the body. Cortisol promotes 
production of glucose in the body, which aids individuals in better preparing to fight or flee real 
or perceived threats in the environment. Cortisol regulates a variety of processes in the body 
including the immune system and metabolism. This hormone has been referred to as “the stress 
hormone” due to its modulation of changes in the body that typically occur as a result of stress 
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(i.e., blood glucose levels; Dickerson & Kemeny, 2004). Cortisol levels naturally vary 
throughout the day among individuals, with levels typically being highest at within 20-30 
minutes after waking (Miller, Chen, & Zhou, 2007) and gradually decreases throughout the day. 
The overall impact of too much cortisol has been shown to have detrimental physical and 
psychological impacts, including weight gain, high blood pressure, and mood swings. In 
addition, low levels of cortisol may result in weight loss, fatigue, and dizziness (Lupien, Maheu, 
Ficco, & Schramek, 2007). Given the substantial impact that cortisol may have, both physically 
and psychologically, this hormone has proven to be a substantial marker of immune functioning 
in a variety of different populations. Cortisol levels are typically collected as baseline 
measurements to assess differences between groups, following experimental inductions, and as a 
marker of diurnal physiological variability (Segerstrom & Miller, 2004).  
There has been a substantial amount of research examining perseverative processes in 
relation to cortisol. A 2006 review of studies supporting the PCH indicated that worry and 
rumination are linked to cortisol reactivity (i.e., increased or decreased production of cortisol as a 
result of a stressor; Brosschot et. al, 2006; Thomsen et. al, 2004). Cortisol has also been 
examined in relation to rumination, particularly while participants undergo social evaluative 
stressor tasks, as these tasks have been shown to be particularly able to elicit cortical responses 
among participants both with and without psychopathology (Dickerson & Kemeny, 2004). 
Research by Zoccola and colleagues (2008) demonstrated that following a social evaluation task 
(SET) participants experienced higher rumination compared to a control condition. This 
heightened rumination was subsequently related to a prolonged and amplified cortisol response, 
a physiological marker commonly used to assess HPA axis activity and dysregulation.  Similar 
research by this group has found that compared to a distraction condition, healthy individuals 
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who were explicitly instructed to ruminate in response to the Trier Social Stress Test (TSST) had 
significantly higher levels of saliva-derived cortisol post-task (Zoccola, Figueroa, Rabideau, 
Woody, & Benencia, 2014). Higher daily levels of self-focused rumination (i.e., perseverating on 
past failures or flaws within oneself) has also been shown to be associated with higher mean 
daily cortisol levels compared to individuals low in rumination (Huffziger, Ebner-Priemer, 
Zamoscik, Reinhard, Kirsch, & Kuehner, 2013). In terms of worry, experimental manipulations 
of worry during a stressful context were associated with greater cortisol reactivity across healthy 
individuals as well as those diagnosed with SAD. In addition, worry was associated with 
increased cortisol during the recovery period post-task (Lewis, Yoon, & Joorman, 2017). The 
2016 meta-analysis on the impact of perseverative cognition on physical health demonstrated a 
significant impact of experimental manipulations of perseveration on cortisol, such that greater 
perseveration led to increases in cortisol levels from baseline to post-manipulation. Further, 
correlational studies demonstrated a significant relationship between higher perseveration and 
higher cortisol levels (Ottaviani et al., 2016). Taken together, these findings indicate that cortisol 
can be significantly impacted both at baseline and throughout experimental manipulations of 
stress and related processes in psychologically healthy individuals. Although it is difficult to 
determine causality in these studies, it appears that worry and rumination may play an important 
role in influencing cortisol levels. Importantly, many of these studies highlight cortisol reactivity, 
where cortisol may be either increasing or decreasing during an experimental manipulation, 
highlighting a need for increased research within the field to better understand which processes 
may exacerbate or inhibit cortisol production.  
Cortisol levels have also shown to be dysregulated among individuals with formal 
anxiety disorder diagnoses as well. Among individuals diagnosed with GAD, given its 
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characterization by high degrees of perseverative processes such as worry, findings have been 
less consistent. Particularly, a 2010 cross-sectional study demonstrated that individuals with 
GAD, compared to healthy controls, had lower levels of cortisol concentrations in the hair, one 
commonly used marker of short-term cortisol secretion (Steudte, Stalder, Dettenborn, Klumbies, 
Foley, Beesdo-Baum, & Kirschbaum, 2011). Salivary cortisol is also associated with greater 
symptom severity among people with GAD as well as trait worry (Mantella et. al, 2008). This is 
generally consistent among basal serum-derived cortisol levels in individuals with panic disorder 
(Staufenenbiel, Pennix, Spijker, Elzinga, & Rossum, 2013), although other findings have 
demonstrated higher cortisol levels among participants with panic disorder (Wedekind, 
Bandelow, Broocks, Hajak, & Ruther, 2000). These findings are not always clear, however, as 
greater PTSD symptom severity is associated with lower levels of morning and evening cortisol 
levels (Doruk, Gulsun, & Balikci, 2015) and has been shown to be significantly lower than in 
healthy controls (Yehuda, Teicher, Trestman, Levengood, & Siever, 1996). A 2007 meta-
analysis comparing basal cortisol levels between people with PTSD and healthy controls found 
no significant differences between the two groups, with significantly lower levels among 
participants with PTSD only being present when cortisol was assessed through plasma or serum, 
but not salivary cortisol (Meewisse, Reitsma, Vries, Gersons, & Olff, 2007). Across all anxiety 
disorders, correlational research has shown significantly higher cortisol awakening levels in 
people with anxiety disorders compared to controls as well as higher cortisol levels one-hour 
post-awakening (Vreeburg et. al, 2010). Although findings have been mixed, the extant literature 
indicates that regardless of formal anxiety disorder diagnosis, processes that may underlie these 
disorders, such as worry and rumination, may associate with dysregulated patterns of cortisol 
responding and higher levels of basal cortisol levels compared to controls. Cortisol therefore 
IMMUNOLOGICAL AND PHYSIOLOGICAL IMPACT OF WORRY 
20 
 
represents a worthwhile area of investigation in understanding the physiological impact of 
perseveration.  
Integrative Research of Physical Health Outcomes and Perseverative Cognition 
Taken together, previous research examining the PCH in relation to HPA axis and HRV 
dysregulation have demonstrated that people who are high in perseverative processes such as 
worry and rumination, both at the state and trait level, are more likely to experience lower HRV 
and higher cortisol responses compared to those who are low in these perseverative processes. 
To date, however, there has been no research examining whether immunological outcomes such 
as cytokine levels (a marker typically used to assess chronic inflammation) are associated with 
increased rates of worry and/or rumination. Research has begun to explore relationships between 
HRV and inflammation along with cortisol and inflammation given the influence that the 
activation of the HPA axis has on the cascade of increases in these processes. A 2008 study of 
physically and psychologically healthy men found that decreased HRV, interpreted as overall 
autonomic rigidity, was associated with higher levels of CRP and IL-6 (Lampert et. al, 2008). 
Prospectively, chronic low levels of HRV are associated with increases in inflammation, which, 
as mentioned above, may subsequently put individuals at an increased risk of experiencing 
negative health outcomes (Katon, Maj, & Sartorius, 2011; Kissane, Maj, & Sartorius, 2011; 
Thayer, Yamamoto, & Brosschot, 2010). The study by Zoccola and colleagues (2014) that found 
greater post-task cortisol in individuals who were instructed to ruminate rather than distract 
found that CRP levels were significantly higher in the rumination condition and did not return to 
baseline by the end of the experiment. Individuals in the distraction condition, although 
demonstrating increases in CRP during the TSST, experienced these levels returning to baseline 
by the end of the experiment. A recent meta-analysis found that higher perseverative cognition 
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was associated with greater blood pressure, higher heart rate, higher levels of cortisol, and lower 
HRV in both experimental and correlational studies (Ottaviani, Thayer, Verkuil, Lonigro, 
Medea, Couyoumdjian, & Brosschot, 2016). Given that the majority of this research has been 
correlational in nature, it is difficult to disentangle whether changes in cortisol and HRV 
contribute to higher levels of pro-inflammatory cytokines. Additionally, to date, no research has 
examined the combination of these autonomic and immunological processes within the context 
of perseveration. 
Although there have been a number of studies that have looked at the experimental 
impact of perseveration on HRV and cortisol, to date, there has been no research that has 
examined inflammation within this context. A number of studies have examined increases in 
inflammation as a result of social stressors to understand the impact of stress on inflammation 
(Steptoe, Hamer, & Chida, 2007). Results of this 2007 meta-analysis indicated a small but 
significant impact of experimental stressors on inflammation from pre to post intervention, 
signifying significant increases in pro-inflammatory cytokines from baseline to post-task. 
However, less is known in regard to how the perseverative processes of worry and/or rumination 
may impact immunological functioning. The results of this meta-analysis examining have 
demonstrated that a significant increase in IL-6 and IL-1β across 13 studies from baseline to 
post-task and marginally significant increases in the c-reactive protein (CRP; Steptoe et. al, 
2007). The majority of tasks utilized a traditional or modified version of the TSST (9 studies) 
highlighting an important role of social stress on inflammation. However, all of these studies 
utilized either physically and psychologically healthy individuals or individuals with chronic 
health conditions with the exception of one study that utilized participants diagnosed with major 
depressive disorder (MDD). Since the publication of this meta-analysis in 2007, there continues 
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to be no experimental manipulations of inflammation in relation to worry. Although the research 
examining inflammation and cortisol by Zoccola and colleagues (2014) has highlighted the 
importance of the perseverative processes and immunology link, there continues to be a 
discrepancy in our understanding of the impact of worry and how these physiological processes 
may be altered as a result.  
The PCH and subsequent research supporting this theory highlights the role that worry 
may have on activating dysregulated physiological responses in the body such as through 
inflammation, cortisol, and HRV via increased activation of the HPA axis. This small but 
important body of research examining experimental manipulations of perseverative cognition 
highlight autonomic and cortisol outcomes and point towards a potential causal role that 
perseveration may have on these processes. Given that dysregulation of HRV, inflammation, and 
cortisol have been shown to promote deleterious health outcomes in the long term, it may be 
important to understand the mechanistic role that perseveration may play in exacerbating these 
outcomes. The examination of such data could have important implications in highlighting the 
necessity of reducing perseveration in an effort to promote better physical health via increased 
regulation of these physiological processes.  
The Current Study 
This study sought to examine dynamic changes in chronic inflammatory proteins, HRV, 
and cortisol throughout a worry and relaxation manipulation in individuals with varying degrees 
of trait worry. Participants underwent an experimental manipulation of worry and relaxation. 
Inflammatory cytokines, cortisol, and HRV recordings were collected throughout the 
experiment. The aims and specific hypotheses for this project were as follows:  
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1.To examine the interrelationships of inflammatory cytokines, heart rate 
variability, and cortisol at a baseline measurement and throughout an experimental 
manipulation of worry and relaxation. I hypothesized that inflammatory cytokines 
(pro-inflammatory markers IL-6, TNF- α, IL-1β, and IFN- γ), HRV, and cortisol would 
covary at baseline and throughout the worry and relaxation manipulations. 
1. To determine if trait worry moderates the relationship between inflammatory 
cytokines, heart rate variability, and cortisol at baseline and throughout the worry 
and relaxation inductions. It was hypothesized that individuals high in trait worry 
would not demonstrate significant differences in inflammatory cytokines, cortisol, and 
HRV at baseline compared to people low in trait worry. Further, I hypothesized that there 
would be a significant change in inflammatory cytokines, HRV, and cortisol from 
baseline to post worry induction both in people who experience high and low degrees of 
trait worry. Among people higher in trait worry, I hypothesized that there would be 
significantly greater levels of inflammatory cytokines and cortisol and significantly lower 
HRV post worry induction than low trait worriers. Finally, it was hypothesized that 
individuals higher in trait worry would maintain increased levels of pro-inflammatory 
cytokines and cortisol as well as low HRV from the worry to relaxation inductions. 
Among people low in trait worry, I hypothesized that there would be a significant change 
in these markers post-worry induction compared to post-relaxation induction, such that 
inflammatory cytokines would be significantly lower post relaxation compared to post 
worry manipulations. Among low trait worriers, I also hypothesized that they would 
experience significantly greater HRV and lower cortisol levels following the relaxation 
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manipulation compared to worry manipulation and subsequently return to their baseline 
levels of physiological functioning.  
2. To examine temporal relationships among inflammatory cytokines, heart rate 
variability, and cortisol through baseline and the worry and relaxation 
manipulations. As an additional exploratory hypothesis, I hypothesized that changes in 
HRV and cortisol would precede the changes in inflammatory cytokines throughout the 
experiment. Specifically, I hypothesized that changes in HRV and/or cortisol from 
baseline to the worry condition would precede changes in inflammation from the worry 
to relaxation condition. As an extension of this, I further hypothesized that trait worry 
would moderate this relationship, in that trait worry would interact with changes in HRV 
and cortisol to differentially predict changes in inflammation among high and low trait 
worriers. I hypothesized that the impact of changes in HRV and/or cortisol on 





 Participants were community members between the ages of 18 – 65 years old. All 
participants were required to be over 18 years old, be able to read and understand English, and be 
free of any autoimmune or inflammatory diseases. Participants were also excluded if they were 
on a consistent dose of medications that specifically has been shown to alter immunological 
functioning (i.e. daily prescribed use of NSAIDS, steroids, or SSRIs) or suffered from any 
diagnosed heart conditions. Exclusion criteria also included the presence of bipolar I disorder, 
alcohol or substance dependence, or active psychosis. Finally, due to the serum extractions, 
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participants were excluded if they endorsed a blood injury/injection phobia during a prelimnary 
phone screen (see below for phone screen details).  
Screening Tools 
All people interested in participating in the current study completed a brief phone screen 
to determine basic eligibility criteria. Phone screens were conducted by research assistants in the 
Regulation of Emotion in Anxiety and Depression (READ) Lab at Teachers College, Columbia 
University. First, information was obtained regarding the individual’s age, occupation/student 
status, medication usage, and physical health (e.g. heart conditions, autoimmune and/or 
inflammatory conditions). All interested individuals were then screened using the Penn State 
Worry Questionnaire (PSWQ; see below). Although a formal cutoff score was not used, ensuring 
proper representation of four different quadrants of PSWQ scores aided in the stratification of 
recruitment. These quadrants represented low trait worry (PSWQ scores below 30), low-
moderate trait worry (PSWQ scores between 31 and 45), moderate-high trait worry (PSWQ 
scores between 46 and 64), and high trait worry (PSWQ scores between 65 and 80), with 
approximately 25% of all participants being represented in each group. This type of stratification 
ensured a sufficient breath of worry symptoms are represented within the total sample. This 
stratification was important in light of previous research that suggested low trait rates of 
perseveration for individuals may not be successful in altering physiological outcomes as the 
result of the experiment (Ottaviani et al., 2016). However, at the same time, this grouping was 
consistent with ideas posited by the PCH in that chronic and excessive levels of worry 
characterized by a diagnosis of GAD may not be necessary in order to demonstrate perseverative 
cognition altering physiological activity. Based on previous research examining cutoffs for the 
PSWQ in identifying worry that may be consistent with a diagnosis of GAD (Mennin, Fresco, 
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Heimberg, & Turk, 1999; Ruscio 2002; DiNardo & Barlow, 1988), a cutoff score of 56 or above 
was utilized to categorize high trait worriers in all analyses.  
The phone screen also contained questions related to diagnostic exclusionary criteria. As 
stated above, these diagnostic exclusions included bipolar I disorder, alcohol or substance 
dependence, active psychosis, and/or a blood injury/injection phobia. Potential participants were 
asked several questions to assess the potential presence of the disorders. The screening question 
for bipolar disorder was the following: “Have you ever been diagnosed with bipolar disorder?” 
The screening question for alcohol and/or substance dependence was the following: “Have you 
ever had a problem with alcohol and/or drugs? If so, is this something that you are currently 
struggling with?” In order to assess for active psychosis, participants were asked, “Have you ever 
heard things that other people could not hear or saw things that other people could not see?” 
Responses for each of these questions were recorded as a yes or no. Any individual who 
endorsed a yes for any of these questions was informed that they are unable to participate.  
Potential participants were also asked a series of questions relating to a diagnosis of 
blood injury/injection phobia (i.e., are you especially afraid of needles, seeing blood, or getting a 
shot?). Potential participants were also asked if they have ever fainted in the context of being in a 
doctor’s office or getting a shot/blood drawn to assess whether the potential participant would be 
likely to experience a vasovagal response during the experiment. If individuals responded yes to 
any of these screening items, they were informed that they were unable to participate in the 
study.  
If participants were deemed able to withstand the blood draw portion of the study based 
off of the screening questions, were within the age specifications, and did not endorse any 
chronic illnesses that are known to impact cardiovascular or immunological functioning, a study 
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visit was scheduled by the research assistant conducting the phone screen. All information 
obtained during the phone screen was recorded in a password-protected Microsoft Excel sheet 
within the READ Lab at Teachers College, Columbia University. Following scheduling of the 
study visit, all responses were de-identified with a unique subject ID number.  
Self-Report Measures 
Penn State Worry Questionnaire (PSWQ): The PSWQ (Meyer, Miller, & Metzger, 1990) 
is considered to be the gold standard measure of pathological worry. This 16-item self-report 
measure requires all participants to respond these questions on a 5-point Likert-type scale 
ranging from 1 (not at all typical of me) to 5 (very typical of me), which are summed to create a 
total score representing how worried an individual typically (otherwise known as trait worry).  
These total sum scores range from 16-80, with scores of 65 and above indicating a high degree of 
worry congruent with a diagnosis of GAD (Fresco, Mennin, Heimberg, & Turk, 2003). 
Psychometric validation of the PSWQ has yielded strong reliability and validity among healthy 
individuals as well as people diagnosed with GAD (of which worry is a key diagnostic 
characteristic; Meyer et. al, 1990).  
Sociodemographic questions. A questionnaire assessing a number of sociodemographic 
variables that have been shown to be associated with inflammation will also be administered as 
part of the questionnaire battery. This measure will collect data including race, ethnicity, height, 
weight, gender, and age. In addition, information will be collected regarding whether participants 
exercise, drink alcohol, drink caffeine, or smoke (and, if so, how much and how often they 
engage in these behaviors). Finally, information will be collected as to whether the participant 
suffers from a chronic illness and, if so, what type of illness. This will allow me to control for all 
necessary variables that may contribute to artificial increases in chronic inflammation.  




 The worry and relaxation conditions were modeled off of previous research utilizing 
worry manipulation tasks to assess contrast avoidance (Llera & Newman, 2010; Borkovec & Inz, 
1990; Fisher & Newman, 2013). Prior to completing the experimental portion of the study, 
participants were asked to list a number of items that they worry about the most, rating them as 
things that they worry about most frequently to least frequently. Upon beginning the worry 
manipulation, participants received instructions on the computer of the following: “Pick your 
most worrisome topic and worry about it as intensely as you can in your usual way for the next 
few minutes. If at any point your mind wanders off track, simply refocus your thoughts back 
onto your worry topic.” (Fisher & Newman, 2013). Participants completed this induction for 10 
minutes while receiving a prompt on the computer screen for 10 seconds every minute. For the 
relaxation condition, participants received the following instructions presented to them on the 
computer screen: “Shift your breathing from your stomach rather than from your chest. Also, 
slow your breathing rate down to a rate slower than usual but not so slow that it is unpleasant or 
uncomfortable. You might do this by counting from one to three as you breathe in evenly and 
then again as you evenly exhale.” Participants completed this induction for 10 minutes while 
receiving a reminder of the instructions on the computer screen for 10 seconds every minute.  
 Previous research has utilized these tasks among low trait worriers, high trait worriers, 
and individuals diagnosed with GAD (Fisher & Newman, 2013). Despite a small sample size (N 
= 23), previous research from our lab has shown a similar worry manipulation has led to 
significantly greater subjective ratings of worry from baseline to post-task in a sample of 
undergraduate students with varying degrees of trait worry as measured by the PSWQ (for 
information on the subjective measure used, see manipulation check section below). These 
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findings demonstrate the utility of these manipulations within experimental research on 
perseveration. Although the task in the original study (Fisher & Newman, 2013) was only three 
minutes per condition and the proposed study utilizes 10-minute long inductions, researchers 
have posited that longer durations of perseveration may promote stronger outcome effects by 
increasing the intensity of experimentally-induced worry compared to these briefer, more 
discrete episodes (Ottaviani et al., 2016). 
Physiological Assessment 
 Participants’ heart rate variability (HRV) was monitored throughout the experimental 
portion of the study using the Polar Watch system. This ambulatory psychophysiological 
measurement device collects HRV data via a band with two electrodes placed across the 
participants’ upper abdomen. The sampling rate for this device provided adequate sampling to 
obtain HRV statistics. Specifically, a sampling rate of 1024hz is at the level required to ascertain 
levels of HRV. HRV requires sampling rates that are higher in order to promote greater 
sensitivity in detecting interbeat interval differences (Allen et al., 2007). HRV data was collected 
continuously throughout the experimental portion of the data during each discrete segment of the 
experiment (i.e., baseline recording, worry manipulation, worry recovery/wait period, relaxation 
manipulation, relaxation recovery/wait period). Data was then uploaded from the device onto a 
computer in the READ Lab for processing and analysis.  
Mean absolute successive interbeat interval differences (MSD) values, a commonly used 
metric of HRV that assesses the average differences in beat-to-beat intervals of the heart, was 
analyzed and obtained using CMetX (Allen et al., 2007). MSD is a putative measure of HRV in 
the clinical psychology literature (Allen et al., 2007). 
Inflammatory and Cortisol Measurement 
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      Inflammatory cytokines were assessed via serum-derived IL-6, TNF- α, IL-1β, and IFN- γ. 
An angiocath was inserted into the participant’s non-dominant arm in order to obtain serum 
samples to test for inflammatory cytokines and cortisol. Blood was drawn at three time points 
(baseline, post worry, post relaxation) and collected via one gold-top 5mL tube per time point by 
trained nurses or phlebotomists at the CTSC. Nurses/phlebotomists inverted the tube 8 -10 times 
post-collection and immediately transferred the blood samples to the Core Lab for preparation, 
storage, and processing. All serum samples were centrifuged at 1200 x g for 15 min at four 
degrees Celsius and stored at -80
 
degrees Celsius until assay. 
Inflammatory markers were analyzed in duplicate in batches utilizing enzyme-linked 
immunosorbent assay (ELISA) by the Core Lab. A multiplex assay kit was used to measure IL-6, 
TNF- α, IL-1β, and IFN-γ. Cortisol samples were also be analyzed in batches using ELISA 
methods. The results of both of these analyses were disseminated via an online results system 
created and monitored by the Clinical and Translational Science Center’s (CTSC) Core Lab of 
Weil Cornell Medical College. All data was reported in picograms (pg) per milliliter (ml) of 
serum and nondetectable amounts of cytokines and cortisol was defined as levels < 0.1 pg/ml.  
Manipulation Check 
The Worry Visual Analog Scale (WVAS; Wichelns, Renna, & Mennin, 2016) was used 
to assess subjective changes in participant worry throughout the experiment. Worry is defined on 
the WVAS as, “talking a lot to ourselves about things that we are concerned about happening in 
the future”. This measure contains two sheets: an anchor sheet and a score sheet.  On the top of 
each sheet is a line representing 0 to 100.  The anchor sheet asks a participant to describe five 
situations, personal to them, that represent differing degrees of worry. The score sheet asks a 
participant to refer to their anchor sheet and give themselves a score between 0 and 100, 
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according to how much worry they are experiencing “at the current moment.”  Using their 
anchor sheet as a guide, the participant rapidly provided a score at baseline, immediately 
following both mentation conditions, and twice throughout the wait period prior to the blood 
draw. Participants then immediately completed the WVAS after each blood draw. Previous 
research has demonstrated that the WVAS is a reliable measure of state-level worry and it has 
shown acceptable levels of convergent and discriminant validity among unselected 
undergraduate and clinical samples (Wichelns et. al, 2016). Participants also completed an 
anchor sheet asking for situations that lead them to feel relaxed. Similar to the WVAS anchor 
scale, participants indicated situations representing relaxation levels at 0, 25, 50, 75, and 100. 
Subjective 0 – 100 rating of their level of relaxation were collected at baseline, immediately 
following the relaxation condition as well as twice throughout the wait period prior to the third 
and final blood draw. The utilization of these measures allowed the examination of subjective 
levels of worry and relaxation throughout the experiment in order to determine whether or not 
the experimental manipulations altered these experiences for participants.  
Procedures 
All data collection took place at the Clinical and Translational Science Center (CTSC) of 
Weil Cornell Medical College. All study procedures took place between 9:00AM – 12:00PM to 
control for diurnal variation of inflammatory and cortisol changes and variability. Participants 
completed informed consent with a research assistant, followed by completing paperwork 
required by the CTSC for the blood draw portion of the study. Following informed consent, 
participants completed a baseline packet of subjective measures including the WVAS and 
RelaxVas anchor sheets, a baseline rating of worry and relaxation, and the PANAS. Participants 
then were instructed on how to properly put on the Polar Watch and band and were given privacy 
IMMUNOLOGICAL AND PHYSIOLOGICAL IMPACT OF WORRY 
32 
 
to do so. They were then brought down the hall to a phlebotomy room where a CTSC nurse 
inserted the angiocath to the participant’s non-dominant arm and drew the first blood sample via 
two 5-ml tubes (T0). Participants then completed a resting baseline for the psychophysiological 
assessment for five minutes followed by the worry mentation for 10 minutes. Immediately 
following the worry mentation, participants were instructed to undergo a thirty-minute rest 
period in order to allow time for immunological and cortisol changes to take place. Previous 
research has demonstrated that longer wait times post-experimental inductions or stressors are 
associated with stronger effects in examining both inflammation and cortisol (Steptoe et. al, 
2007; Dickerson & Kemeny, 2004). During this thirty-minute rest, participants completed the 
WVAS every 10 minutes. At the end of the rest period, nurses/phlebotomists drew two 5mL 
tubes of blood through the angiocath (T1). Participants then underwent the same sequence of 
procedures for the relaxation condition, including the thirty-minute wait period and subsequent 
blood draw (T2). Following completion of the worry and relaxation conditions, wait periods, and 
blood draws, participants were detached from the psychophysiological equipment and the nurse 
removed the angiocath. Lastly, participants completed self-report questionnaires on Qualtrics to 
assess trait-level worry, rumination, anxiety, depression, and emotion dysregulation, as well as 
questions related to their demographics and physical health. Upon completion of the 
questionnaires, participants were compensated $50, debriefed, and dismissed. 
Data Analysis Plan 
Power analyses were conducted using G Power software. A power analysis conducted in an 
effort to detect a medium effect size (Cohen’s d = 0.50) with 80% power yielded the necessity of 
a total sample size of at least 75 participants total (i.e., approximately 37 participants per group). 
All analyses were completed within SPSS software. All inflammatory, cortisol, and HRV data 
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will first be examined for normality, as these metrics are oftentimes skewed. If data is deemed to 
be non-normal, a log-10 or square root transformation will be used in an effort to normalize the 
skew of the data. Effect sizes are also reported for all analyses to determine the magnitude of 
each effect for each result. 
Given that cortisol, HRV, and inflammation have been shown to be associated with several 
sociodemographic factors, bivariate correlations were run between all physiological outcome 
variables at baseline and BMI, gender, race, age, and smoking status to determine whether these 
variables were significantly related to the outcome variables. Analyses were run with all 
covariates in the model based off of previous findings suggesting doing so when working with 
markers of immune function (O’Connor et al., 2009).  
In order to first determine whether or not the worry and relaxation manipulations promoted 
increased worry or relaxation across participants, paired sample t-tests were employed for 
WVAS and RelaxVAS ratings. Comparisons were made between baseline WVAS and 
RelaxVAS and post worry induction WVAS and RelaxVAS ratings to determine whether the 
worry induction significantly increased participants’ subjective state-level ratings of worry while 
reducing relaxation. An additional paired sample t-test was run to assess changes in WVAS and 
RelaxVAS ratings both from baseline and post worry to the post relaxation induction to 
determine whether the relaxation condition significantly increased subjective state-level ratings 
of relaxation while concurrently reducing state-level subjective ratings of worry. 
In order to examine changes in chronic inflammation, cortisol, and HRV across baseline, 
worry, and relaxation, separate repeated measures ANOVAS (i.e., one test for cortisol, one test 
for HRV, and one test for each type of inflammatory marker) were conducted collapsing all 
participants together. In order to examine Aim 1 and assess how inflammatory cytokines, HRV, 
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and cortisol relate to one another at baseline and throughout the experimental conditions, mixed 
linear models (MLMs) were used to assess how these variables co-vary throughout the three 
study conditions (i.e., baseline, worry, relaxation). Separate models were used for each type of 
inflammatory marker and its relationship to HRV and cortisol. Models were based on random 
intercept or random slope and intercept if it was found that the addition of both random effects 
significantly improves the model, as indicated by comparing -2LL values for both analyses. 
Independent sample t-tests were conducted for HRV, cortisol, and each inflammatory marker 
in order to assess the first hypothesis of Aim 2 and determine how these variables compare at 
baseline between people high and low in trait worry. Two separate 2 (high and low trait worry) 
x3 (baseline, post worry, post relaxation) ANOVAs were conducted in order to test the second 
hypothesis of Aim 2 of the current study with a specific interest in examining the within-between 
interaction. Separate ANOVAs were run for each inflammatory marker as well as for HRV and 
cortisol. As applicable, the non-parametric equivalents of these tests were run for any data that 
were deemed as non-normal if it was not possible to correct the data via a log10 or square root 
transformation. Specifically, Mann-Whitney U tests were used to examine differences in 
physical functioning between the participants high and low in trait worry. Further, Friedman tests 
for repeated measures of related samples was utilized as an equivalent of the RM ANOVA to test 
for changes in physical functioning throughout the three conditions (baseline, worry, relaxation). 
Given that post hoc tests are not possible when using nonparametric tests, the Friedman tests 
were followed by separate Wilcoxon Signed Rank tests to determine the specific breakdown of 
differences across conditions (e.g. differences between baseline and worry, worry and relaxation, 
etc.)  
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In order to examine Aim 3, time-lagged mixed linear models (MLMs) were utilized. Data 
was restructured in such a way that time-lagged values for HRV and cortisol were computed by 
including baseline and post worry values while inflammatory data was restructured to include 
post worry and post relaxation values. The resulting restructured data set included two different 
timepoints (baseline-post worry and post worry-post relaxation). Time was be entered as a 
repeated measure at Level 1 for all models. HRV or cortisol was included as a continuous 
variable at another level with each inflammatory marker included as the dependent variable in 
separate models. In order to examine the second hypothesis of Aim 3 and examine moderation of 
this effect, each model was re-run with group (high versus low trait worry) entered as an 
additional covariate with the interaction between either HRV or cortisol and group entered as a 
separate fixed factor. Models were based on Maximum Likelihood Estimation. Models were also 
based on random intercept or random slope and intercept if it is found that the addition of both 
random effects significantly improves the model, as indicated by comparing -2LL values for both 
analyses. If not, only a random intercept was included. Effect sizes are also reported for all 
analyses to determine the magnitude of each effect for each result.  
3. Results 
 
Missing Data and Outliers 
 Ninety participants were enrolled in the current study. Outliers were examined for all 
outcome variables and removed. Overall, five participants were excluded from analyses for 
having values more than 1 standard deviation above the mean on at least one outcome variable, 
resulting in a total final sample of 85. The vast majority of IL-1β levels for participants were 
below a detectable limit – only 18 of a possible 255 samples had levels > 0.1. As a result, IL-1β 
was not utilized in any of the subsequent analyses. In addition to not having samples for this 
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marker, seven participants did not have their blood drawn and were subsequently excluded from 
analysis. Three of these participants fainted. One participant had blood pressure that was deemed 
too high to participate based on the nurses’ recommendation at the CTSC. An additional 
participant was suspected of being under the influence of drugs and/or alcohol upon presentation 
to the study and was subsequently dismissed. Finally, two participants completed their baseline 
blood draw but terminated their participation in the study prior to completing all study 
procedures. 
 An additional 10 participants were missing HRV data for some portion of the collection 
period. Of these missing data, four were due to errors by the research assistant running the study 
(e.g., not starting or stopping the HRV recording at the appropriate time, forgetting to start HRV 
recordings during the experiment). Four participants had HRV data collected throughout the 
study but due to errors on the Polar Watch device the data was unable to be downloaded from the 
device and processed. Finally, two participants had partially collected HRV data but did not have 
data for all three timepoints due to space issues on the Polar Watch.   
Demographic Characteristics 
Participants’ mean age was 30.88 years old (SD = 11.42). The sample was predominantly 
female (n = 53, 62.4%). The sample also demonstrated racial diversity overall. Self-reported race 
for this sample was:  39.2% White (n = 31), 15.2% African American (n = 12), 24.1% Asian 
American or Pacific Islanders (n = 19), 5.1% as mixed race (n = 4), 1.3% as ‘other’ (n = 1), and 
15.2% of the sample self-identified their race as Hispanic/Latino (n = 12). Overall, 57.5% of 
participants (n = 46) were undergraduate or graduate students, 31.3% were employed either full-
time or part-time (n = 25), and 11.3% unemployed (n = 9) and one person did not report these 
data. Participants had a mean screening PSWQ score of 49.20 (SD = 14.73) with 33 participants 
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being categorized as high worriers, indicating overall success in recruiting participants into the 
different worry quadrants.  
Examination of Covariates 
Correlations between potential covariates and all physiological outcome variables at 
baseline are presented in Table 1. Ten participants enrolled in the study were prescribed a 
psychiatric medication while 14 were prescribed medication for a medical or physical issue or as 
a method of birth control. Bivariate correlations demonstrated no significant relationships 
between medication usage and any of the outcome variables (all ps > .34). In terms of age, there 
was a significant relationship between HRV (r = -.40, p < .001). Age was also significantly 
related to baseline IL-6 (r = .29, p < .01) and TNF- α (r = .30, p < .01). There were no significant 
relationships between age and IFN-γ (r = .04, p = .69) or cortisol (r = -.11, p = .52). There were 
no significant relationships between race and any of the outcome variables (all ps > .17). In terms 
of gender, a point biserial correlation indicated that there was a significant association between 
gender and TNF- α (r = -.34, p = .001). No other significant point biserial correlations between 
gender and outcome variables emerged (all ps > .06). Given point biserial correlations assume 
one continuous and one categorical variable that is dummy-coded, the direction of the 
associations between outcome variables and gender can be ignored.  
On average, participants had a mean body mass index (BMI) of 24.76 (SD = 5.90). Three 
participants indicated that they were diagnosed with a medical condition (one polycystic ovarian 
syndrome, one irritable bowel syndrome, one obstructive sleep apnea). BMI was significantly 
and positively correlated with baseline TNF- α (r = .33, p < .01) and IL-6 (r = .30, p < .01). 
There were no other significant relationships between BMI and the other outcome variables (all 
ps > .10).  Finally, smoking status was significantly associated to both IL-6 (r = -.77, p < .001) 
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and IFN-γ (r = -.82, p < .001) while no other significant correlations emerged with the other 
outcome variables (all ps > .38). Similar to the dummy-coded gender variable, the point biserial 
correlation of the relationship between smoking status and all outcome variables can ignore the 
direction of the associations.  
Although a number of proposed covariates were not associated with the outcome 
variables at baseline, previous research has suggested the necessity of controlling for these and a 
number of other variables despite their relationship to outcome given the strong influence that 
they have demonstrated on inflammation and other biomarkers in previous studies (O’Connor et 
al., 2009). Given this, all proposed covariates were controlled for in the subsequent analyses 
when possible as a conservative assessment of the influence of such variables on immune, 
endocrine, and cardiovascular function.  
Normality Tests 
Skew and kurtosis were examined to determine whether or not the inflammatory, cortisol, 
and HRV data were normally distributed. HRV data was derived from the MSD variable. The 
MSD was non-normal at baseline (Shapiro Wilk = .93, p = .001), worry (Shapiro Wilk = .92, p = 
.001), and relaxation (Shapiro Wilk = .96, p = .02). Performing a square root transformation on 
the MSD variable corrected the skew and kurtosis at baseline (Shapiro Wilk = .99, p = .70), 
worry (Shapiro Wilk = .98, p = .20), and relaxation (Shapiro Wilk = .99, p = .73), respectively. 
Results indicated that IL-6, TNF-α, IL-1b, and IFN-γ were not normally distributed. Square root 
and log 10 transformations were utilized, but these transformations did not normalize the data. 
Further, the cortisol data were not normally distributed. Square root and log 10 transformations 
did not normalize the data. Tables 2, 3, 4, 5, and 6 provide information regarding normalizing the 
IMMUNOLOGICAL AND PHYSIOLOGICAL IMPACT OF WORRY 
39 
 
data for HRV, cortisol, IL-6, TNF-α, and IFN-γ, respectively. The inclusion versus exclusion of 
outliers did not impact normality of the data. 
 Manipulation Check 
 Means and standard deviations for the WVAS and RelaxVAS are presented in Figure 1. 
In order to examine whether or not the worry and relaxation tasks promoted an increase in 
subjective worry and relaxation, independent sample t-tests were conducted to examine changes 
from baseline to post-worry or post-relaxation among all participants. Overall, results indicated a 
significant increase in subjective ratings of worry following the worry task for all participants (t 
= -9.83, df = 79, p = 0.00, cohen’s d = -1.54). Further, there was a significant increase in 
subjective ratings of relaxation following the relaxation task compared to baseline (t = -7.34, df = 
79, p = 0.00, cohen’s d = -1.15). Further, the worry condition led to a significant reduction in 
relaxation across all participants (t = 6.06, df = 79, p = 0.00, cohen’s d = 0.95), while the 
relaxation condition led to a significant reduction in worry across all participants (t = 14.42, df = 
79, p = 0.00, cohen’s d = 2.25). These results can be found in Table 3.  
Aim 1: Covariation of immune markers, cortisol, and HRV 
 HRV data was able to be corrected via transformation while the inflammatory and 
cortisol data remained non-normal despite transformation. Despite the violation of assumptions 
of normality, the covariation analysis was run to examine Aim 1. Separate covariance analyses 
were run to determine the relationship of change with each inflammatory marker and HRV and 
cortisol separately. Results are presented in Table 5. In terms of model fit, random slopes were 
included in all models. The inclusion of both random slope and intercept did not improve the 
models based on -2LL values. Therefore, the final results of the model including random slope 
only are reported. Each model controlled for all related sociodemographic variables.  
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Overall, the three variables did not significantly covary throughout the different 
conditions when examining IFN-γ, IL-6, and TNF-α in separate models. In examining the 
manner in which HRV and cortisol alone covaried throughout the study conditions, results 
demonstrated that there was not a significant relationship between the two across time (p = .18), 
indicated that HRV and cortisol did not have a similar rate of change to one another throughout 
the three study conditions.   
Aim 2: HRV Data 
 All HRV analyses utilized the square root transformed MSD variables. Means and 
standard deviations of the non-transformed variables for each condition are presented in Table 4. 
Age was controlled for in all of the following analyses given the significant correlation between 
age and baseline MSD.  
 Across all participants, paired sample t-tests revealed a significant different in MSD 
between baseline and the worry condition (t = 2.92, df = 74, p = 0.01, cohen’s d = .68) and 
between baseline and the relaxation condition (t = -3.35, df = 71, p = 0.001, cohen’s d = -.80) as 
well as a significant difference in MSD between the worry and relaxation conditions (t = -5.25, 
df = 70, p = 0.00, cohen’s d = -1.26). A repeated measures ANOVA revealed a significant 
difference in MSD across all participants between the three conditions (F [2,69] = 14.17, p = .00, 
partial eta squared = .29). Pairwise comparisons corroborated findings from the paired sample t-
tests, revealing a significant difference between the different conditions such that MSD 
decreased significantly across all participants from the baseline to worry conditions, and that 
MSD was significantly higher in the relaxation condition compared to both the baseline and 
worry conditions. 
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There was not a significant difference in baseline MSD between participants high and 
low in trait worry (t = .79, df = 70, p = 0.44, cohen’s d = .13). Overall, participants high in trait 
worry demonstrated higher HRV compared to low trait worriers. The group (high versus low 
PSWQ) x condition interaction yielded a trending difference in MSD across conditions (F [2,69] 
= 3.20, p = .07, partial eta squared = .05). Overall, all participants experienced decreased MSD 
during the worry condition compared to baseline, but there was a significantly greater decrease 
in MSD among high trait worriers compared to low trait worriers. Both groups experienced a 
significant increase in MSD between the worry and relaxation conditions. For both groups, MSD 
during the relaxation condition was greater than baseline.  
Aim 2: Cortisol Data 
 Means and standard deviations of the cortisol data across each condition are presented in 
Table 4. Given non-normality of the data that could not be corrected via transformations, 
nonparametric tests were used to assess changes over time throughout the baseline, worry, and 
relaxation conditions and to determine baseline differences between individuals high and low in 
trait worry. Results of the Mann-Whitney U test indicated that there was not a significant 
difference in baseline cortisol between groups (U = 706.00, p = 0.71).  
 Results of the Friedman test indicated an overall significant difference among all 
participants in cortisol between the baseline, worry, and relaxation conditions (X
2 
= 25.22, p < 
.001, cohen’s d = 1.32). Wilcoxon Signed Ranks tests to follow up on this change indicated 
significant differences among each condition (all ps < .01). Specifically, contrary to study 
hypotheses, results indicated that cortisol at baseline was significantly higher than during the 
worry condition (z = -3.71, p < .001, cohen’s d = -.89). Further, consistent with study 
hypotheses, cortisol differed significantly between the worry and relaxation conditions, with 
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cortisol being significantly lower during relaxation compared to worry (z = -2.90, p < .001, 
cohen’s d = -.67). Cortisol was also significantly lower following relaxation compared to 
baseline (z = -4.02, p < .001, cohen’s d = -.98).  
While the data violated the assumptions of normality, the group*condition interaction 
was run to determine the impact of group on cortisol change throughout the experiment. The 
group (high versus low PSWQ) x condition interaction yielded no significant impact of worry 
across conditions (F [2,76] = .403, p = .53, partial η2 = .005). Descriptive and available test 
statistics corroborated this finding, demonstrating a similar trend across time for both high and 
low trait worriers. Cortisol levels, overall, were lower among high trait worriers compared to low 
throughout the experiment, with slight decreases in cortisol among both groups following the 
worry condition which continued to decline slightly following relaxation. The parametric RM 
ANOVA corroborated the findings of the Friedman Test and identified a significant difference in 
cortisol between the three conditions (F
 
= 14.11, p < .001, partial η2 = .16).  
Aim 2: Inflammation Data 
 Means and standard deviations of the inflammatory variables for each condition are 
presented in Table 4. Due to the fact that all inflammatory data were not normally distributed and 
could not be corrected via a lg10 or sqrt transformation, nonparametric tests were used. 
However, results of the group*condition interaction are presented below in order to understand 
the way that group influenced the current findings. 
 IL-6. Results of the Mann-Whitney U test indicated that there were no significant 
differences in baseline IL-6 between participants high and low in trait worry (U = 616.50, p = 
0.16). Results from the Friedman test indicated a significant difference in IL-6 across the three 
conditions (2 = 32.03, p < .001, cohen’s d = 1.59) for all participants. While there were no 
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significant differences in IL-6 between baseline and the worry condition (z = -1.27, p = 0.20, 
cohen’s d = -.28), a significant difference did emerge between the baseline and relaxation 
condition (z = -4.45, p < 0.01, cohen’s d = -1.12). Further, there was a significant difference in 
IL-6 between the worry and relaxation conditions (z = -4.50, p < 0.001, cohen’s d = -1.14). 
Results indicated that although there was a slight, although non-significant increase in IL-6 
levels between baseline and the worry condition, IL-6 levels continued to significantly increase 
throughout the relaxation condition, with the highest levels of IL-6 being present following 
relaxation compared to the other two conditions.  
While the data violated the assumptions of normality, the group*condition interaction 
was run to determine the impact of group on IL-6 change throughout the experiment. The 
group*condition interaction yielded no significant impact of worry on changes in IL-6 
throughout the study conditions (F [2,76] = .002, p = .96, partial η2 = .000). The available test 
statistics and mean changes across conditions for each group demonstrated that participants in 
the high worry group experienced a significantly greater increase in IL-6 following the worry 
condition compared to low trait worriers. IL-6 continued to increase among both groups 
following the relaxation condition, indicating no significant differences between the two groups 
following relaxation. The parametric RM ANOVA corroborated the findings of the Friedman 
Test and identified a significant difference in IL-6 between the three conditions (F
 
= 16.82, p < 
.001, partial η2 = .18). 
TNF-α. There were no significant differences in TNF-α between groups (U = 710.50, p = 
0.63). Results of the Friedman test demonstrated no significant changes in TNF-α across 
participants between conditions (2 = 3.30, p = .19, cohen’s d = .41). Follow-up Wilcoxon Sign 
Rank Tests corroborated this finding, demonstrating no differences in TNF-α between baseline 
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and worry (z = -.70, p = .48, cohen’s d = -.15), baseline and relaxation (z = -1.42, p = .16, 
cohen’s d = -.32), or worry and relaxation (z = -.63, p = .53, cohen’s d = -.14).  
While the data violated the assumptions of normality, the group*condition interaction 
was run to determine the impact of group on TNF-α change throughout the experiment. The 
group*condition interaction yielded no significant impact of worry on changes in TNF-α 
throughout the study conditions (F [2,76] = 2.34, p = .13, partial η2 = .03). Available test 
statistics and variable means demonstrated little to no change in TNF-α among low trait worriers 
throughout the different study conditions. High trait worriers demonstrated an increase in TNF-α 
following the worry condition compared to baseline which decreased marginally following 
relaxation. The parametric RM ANOVA corroborated the findings of the Friedman Test and 
identified no significant difference in TNF-α between the three conditions (F = .615, p = .44, 
partial η2 = .01). 
IFN-γ. Results indicated no significant differences in IFN-γ between participants high and 
low in trait worry (U = 649.00, p = 0.27). Across all participants, results of the Friedman test 
indicated a significant difference in IFN-γ across the three conditions (2 = 49.24, p < .001, 
cohen’s d = 2.42). Follow-up Wilcoxon Sign Rank Tests corroborated this finding, indicating a 
significant difference in IFN-γ between baseline and the worry condition (z = -5.36, p < .001, 
cohen’s d = -1.46). A significant difference also emerged between the baseline and relaxation 
conditions (z = -6.07, p < .001, cohen’s d = -1.79) in addition to the worry and relaxation 
conditions (z = -2.86, p < .01, cohen’s d = -.66).   
Similar to the IL-6 and TNF-α data, the group*condition interaction was run to determine 
the impact of group on IFN-γ change throughout the experiment. The group*condition 
interaction yielded no significant impact of worry on changes in IFN-γ throughout the study 
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conditions (F [2,76] = .095, p = .76, partial η2 = .001). Examining the available test statistics and 
mean changes across conditions for each group, it appeared that participants in the high worry 
group experienced a significantly greater increase in IFN-γ following the worry condition while 
low trait worriers demonstrated a significant decline in IFN-γ between these two conditions. 
IFN-γ continued to increase among high trait worriers following the relaxation condition while it 
continued to decrease among low trait worriers from the worry to relaxation condition. The 
parametric RM ANOVA corroborated the findings of the Friedman Test and identified no 
significant difference in IFN-γ between the three conditions (F = .615, p = .44, partial η2 = .01). 
Aim 3: Changes in cortisol and HRV preceding inflammatory change 
 Transformed data was utilized for the HRV data while inflammatory and cortisol data 
were non-transformed in this analysis. Although assumptions of normality were violated, mixed 
linear models were utilized to examine if changes in HRV and cortisol temporally preceded 
changes in each inflammatory marker across the study conditions, and whether this pattern was 
dependent upon group status (e.g., high or low trait worry). Each model was run with a random 
intercept as well as with a random slope and intercept. Overall, the inclusion of a random slope 
did not improve the model fit based on the -2LL. Subsequently, results are reported below based 
on random intercept models only.  
IL-6. Results of the mixed linear model revealed that changes in HRV from baseline to post 
worry did not significantly predict changes in IL-6 from post worry to post relaxation (F[1, 
132.13) = .007, p = .93, Cohen’s d = .02). When examining the interaction between HRV and 
trait worry, there was a trend in the relationship between changes in HRV from baseline to worry 
and changes in inflammation from worry to relaxation (F[1, 132.11) = 3.26, p = .07, Cohen’s d = 
.40). This model did produce a moderate effect size, highlighting a probable influence of HRV 
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on IL-6 change.  Changes in cortisol from baseline to post worry also did not significantly 
predict changes in IL-6 from worry to relaxation (F[1, 151.78) = 1.48, p = .23, Cohen’s d = .27). 
Trait worry also did not interact with cortisol to significantly influence this relationship (F[1, 
150.26) = .02, p = .90, Cohen’s d = .03). 
IFN-γ. Similar to IL-6, changes in HRV from baseline to post worry did not significantly 
predict changes in IFN-γ from post worry to post relaxation (F[1, 131.62) = 2.11, p = .15, 
Cohen’s d = .32) although the effect size was of a moderate magnitude. The inclusion of trait 
worry within the model demonstrated that worry did not interact with HRV to predict changes in 
inflammation (F[1, 86.05) = .04, p = .85, Cohen’s d = .04). Changes in cortisol from baseline to 
post worry also did not predict changes in IFN-γ from worry to relaxation (F[1, 114.99) = .03, p 
= .86, Cohen’s d = .04). Trait worry did not significantly interact with cortisol to influence 
changes in inflammation (F[1, 120.81) = 1.06, p = .31, Cohen’s d = .23). 
TNF-α. Changes in HRV from baseline to post worry did not significantly predict changes in 
TNF-α from post worry to post relaxation (F[1, 152.38) = .65, p = .42, Cohen’s d = .18). The 
interaction between changes in HRV and trait worry in influencing changes in TNF-α was not 
significant (F[1, 97.64) = .29, p = .59, Cohen’s d = .12). Changes in cortisol from baseline to 
post worry also did not predict changes in TNF-α from worry to relaxation (F[1, 119.96) = .16, p 
= .69, Cohen’s d = .09). There was no significant influence of trait worry on this relationship 
(F[1, 117.59) = 1.91, p = .17, Cohen’s d = .31).  
4. Discussion 
 
This study sought to examine the differential impact of worry and relaxation on several 
physiological markers of health, including HRV, cortisol, and four different inflammatory 
markers (IL-6, IL-1b, TNF-α, and IFN-γ). Specifically, the current study builds off of empirical 
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work of both the contrast avoidance model of worry (Newman & Llera, 2011) and the 
perseverative cognition hypothesis (Brosschot et al., 2006) to better understand the ways in 
which the cognitive process of worry may prolong a psychological stress response, subsequently 
creating sustained physiological activation. The impact of worry and relaxation was examined 
among both high and low trait worriers, and it was first hypothesized that there would be no 
differences between all of these variables between the two groups at baseline. I also 
hypothesized that there would be a significant change in HRV, cortisol, and inflammatory 
markers from baseline to following the worry condition across all participants. Following the 
relaxation condition, it was hypothesized that low trait worriers would return to their baseline 
physiological functioning while high trait worriers would not. Further, this study sought to 
examine whether HRV, cortisol, and inflammation covaried throughout the different conditions. 
Lastly, an exploratory aim of the current study sought to examine whether changes in cortisol 
and/or HRV temporally preceded changes in inflammatory markers throughout the study 
conditions and whether this relationship was influenced by trait worry. To date, this is the first 
known study to examine contrasting worry and relaxation conditions and how such conditions 
impact inflammatory functioning. 
Summary and Interpretation of Study Findings 
The hypothesis that high and low trait worriers would not differ in terms of physiological 
functioning at baseline was supported. Findings indicated that participants high and low in trait 
worry did not have significantly different HRV at baseline. Interestingly, the pattern of HRV 
responding was in the opposite direction of what would be typically expected, in that low trait 
worriers had lower HRV than high trait worriers at baseline. This finding is contrary to previous 
findings demonstrating lower HRV in high trait worriers or individuals diagnosed with GAD 
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compared to low trait worriers or controls (Thayer, Friedman, & Borkovec, 1996). Consistent 
with study hypotheses, there were no differences in inflammatory functioning across any of the 
inflammatory markers when comparing individuals with high and low trait worry. There were 
also no significant differences between the two groups in terms of baseline cortisol levels, 
consistent with some previous research that has examined hair cortisol concentrations in 
participants diagnosed with GAD and healthy controls (Steudte et al., 2011). To date, this is the 
first study that has examined differences in systemic inflammation and cortisol among 
individuals with high and low trait levels of worry independent of psychological diagnoses. 
However, there have been several previous studies that have examined inflammation in the 
context of GAD compared to healthy controls. These studies demonstrated non-significant or 
small differences between these groups (Koh & Lee, 1998; Vieira et al., 2010), demonstrating 
that individuals experiencing chronic, pervasive anxiety and worry did not differ in terms of 
inflammation from their healthy counterparts. The current findings are well in line with this 
previous research, although additional work is needed to determine whether there are other 
processes associated with anxiety that may be contributing to inflammatory and endocrine 
dysregulation among individuals. 
Overall, participants across both groups showed a significant difference in HRV across 
the baseline, worry, and relaxation conditions. Notably, as hypothesized, participants’ HRV was 
significantly lower during the worry condition compared to both baseline and relaxation 
regardless of group. Further, HRV during the relaxation condition across all participants was 
significantly higher than even the baseline condition, demonstrating a significantly relaxing 
physiological effect of the condition. The worry condition, on the other hand, increased 
physiological activation as demonstrated by lower HRV across individuals both high and low in 
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trait worry. When examining differential physiological functioning between the high and low 
trait worry groups, we found partial support that changes in physiology differed across the 
conditions. Results for HRV demonstrated a trending interaction between group (high versus low 
worry) and condition (baseline, worry, relaxation) with a moderate effect size, demonstrating a 
trend towards significant differences in HRV across the conditions based on whether someone 
was prone to high levels of trait worry or not. This finding contributes to a larger body of 
research examining changes in HRV and its association with worry in both laboratory-based and 
self-report studies. Indeed, a recent study looked at worry as a transdiagnostic symptom of 
anxiety disorders and found that trait worry, more so than an anxiety diagnosis, was associated 
with lower levels of HRV during a resting state/baseline collection (Chalmers, Heathers, Abbott, 
Kemp, & Quintana, 2016). While the current findings highlight a pattern of results consistent 
with this previous research, the non-significant group by condition interaction is also consistent 
with some research looking at worry manipulations such as the one used in this study in high 
trait worriers which found a trending effect (Fischer & Newman, 2013). The interaction in this 
study was trending with a moderate effect size and these findings may therefore be consistent but 
slightly less strong with that of Fischer and Newman (2013). 
In terms of inflammatory findings, this study found a significant difference in both IL-6 
and IFN-γ between the baseline and the worry conditions. However, there was no significant 
change in TNF-α between the baseline and the worry conditions. This finding is inconsistent 
with the hypothesis that there would be significant changes in inflammation across both groups 
between baseline and worry, as it was expected that the worry condition would contribute to an 
increased physiological stress response across all inflammatory markers. When comparing 
inflammatory levels from baseline to relaxation and worry to relaxation results appeared to be 
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more mixed. Notably, for IL-6, while there were no significant differences from baseline to 
worry, follow-up analyses demonstrated a significant difference between the baseline and 
relaxation conditions as well as from the worry to relaxation conditions. Further, rates of change 
in IL-6 was similar between the two groups, with slight increases in IL-6 levels observed 
throughout the experiment. This finding highlights the likelihood of inflammatory change 
potentially occurring at a slower rate with levels continuing to change throughout the 
experimental portion of the study. Although this is in contrast to the study hypotheses, given the 
contrasting conditions within a relatively short time window, it is likely that experimentally-
induced inflammatory change for some inflammatory markers may be relatively slow and 
therefore less amenable to this type of study design. Subsequently, it may be important for future 
research to separate out these conditions (e.g., worry and relaxation) to determine whether a 
slow-changing marker such as IL-6 may be amenable to experimental change within one of these 
conditions rather than both. Lastly, consistent with study hypotheses, there was a significant 
difference in IFN-γ across all conditions in a manner that was expected between baseline and 
worry and then decreased from worry to relaxation. Although the group by condition interaction 
was not significant, examining means across conditions for participants high and low in trait 
worry demonstrated a somewhat different pattern of IFN-γ activity between the two groups. 
Notably, IFN-γ levels increased for high trait worriers between baseline and worry and then 
continued to increase during the relaxation condition. Among low trait worriers, the opposite 
pattern was observed – IFN-γ levels decreased from baseline to worry and then continued to 
reduce throughout relaxation. While IL-6 and IFN-γ demonstrated some experimental changes 
throughout the different conditions, findings related to TNF-α showed that it did not change 
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significantly throughout the conditions among either high or low trait worriers. TNF-α may 
therefore be less susceptible to experimental change compared to other inflammatory markers.  
Taken together, the inflammatory findings from the current study lead to larger questions 
within the field of psychoneuroimmunology as to why some seemingly related biomarkers, but 
not others, may change throughout the course of experimental manipulations. The inflammatory 
markers chosen for the current study were based off of a previous meta-analysis examining 
differences in inflammation among individuals with anxiety disorders versus healthy controls 
which highlighted these specific markers to be different among the two groups and therefore 
seemed to be particularly salient among people high in trait anxiety (Renna et al., 2018). A more 
in-depth understanding of these markers and their susceptibility to change in psychological 
experiments likely needs to be derived from a greater understanding of the composition of each 
of these different proteins. This may also be an important step in disentangling the specific 
biological implications of processes such as worrying on the body, as greater specificity in 
biomarkers may help to gain insight into specific physical targets that are impacted while 
perseverating.   
Overall, findings demonstrated a significant change in cortisol throughout the different 
study conditions, in that cortisol actually decreased from baseline to worry across participants 
and continued to decrease following relaxation. This finding is partially in support of the study 
hypotheses, as it highlights that cortisol functioning does decrease following experimentally-
induced relaxation, but it is not necessarily impacted in the expected direction following 
experimentally-induced worry. Further, the inclusion of both worry and relaxation conditions in 
a fixed order makes it difficult to ascertain the differential impact of the two conditions. 
Although the interaction between group (high versus low trait worry) and condition was not 
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significant, the general pattern of mean change of cortisol throughout the condition demonstrated 
similar changes between both high and low trait worriers. In terms of methodological 
considerations, a possible interpretation of these lack of results is that cortisol is not necessarily 
sensitive to these types of experimental inductions, as this was the first study to look cortisol 
responses as a result of experimental inductions of worry and relaxation. The current study 
utilized serum-derived cortisol levels in order to reduce participant burden, as cortisol levels 
could be obtained through the same sample as inflammatory markers. However, serum-derived 
cortisol is less common within the field compared to saliva-derived samples via the passage 
drool method. As a result, it may also be difficult to interpret the current findings in the context 
of other cortisol research within the field using different sampling methods. 
Previous research looking at cortisol has found both higher and lower levels of cortisol 
following experimental induction among participants with distress symptoms (e.g., anxiety, 
depression, rumination) making it difficult to contextualize the current findings within the larger 
body of literature in the field. The 2004 meta-analysis by Dickerson and Kemeny highlighted 16 
studies utilizing an experimental emotion induction, which were comprised of both idiographic 
and nomothetic inductions. Overall, 8 of the 16 studies demonstrated a negative effect size, 
indicating that cortisol levels went down throughout the stressor period. Four of these 16 studies 
had positive effect sizes while four results were null. Taken together with these findings, the 
current study’s decrease in cortisol from baseline through the worry and relaxation conditions 
may be relatively consistent with other similar types of experimental inductions. One potential 
theory from the examination of previous research is that the findings from the current study 
might highlight a blunted cortisol response, in that participants actually demonstrated less 
cortisol reactivity in response to a stressor than what was anticipated. If so, this finding is 
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consistent with a previous meta-analysis demonstrating a blunted cortisol response among 
women with both anxiety and depressive disorders compared to healthy controls (Zorn, Schur, 
Boks, Kahn, Joels, & Vinkers, 2017). More recent research has also shown an association 
between anxiety symptoms and less cortisol reactivity to a TSST compared to depressive 
symptoms (Fiksdal, Hanlin, Kuras, Gianferante, Chen, Thoma, & Rohleder, 2019). While this 
study did not examine worry specifically, it highlights important potential pathways through 
which symptoms associated with anxiety or anxiety disorders may impact cortisol reactivity. 
However, overall, findings remain mixed within the field, as the findings from the current study 
are inconsistent with other recent research looking at baseline correlations between 
worry/rumination and cortisol as well as cortisol reactivity during a TSST. This study found that 
worry was associated with higher cortisol reactivity following the TSST compared to rumination 
in both healthy controls and individuals diagnosed with social anxiety disorder (Lewis, Yoon, & 
Joorman, 2018). Independent of explanations for the lack of cortisol findings in the current 
study, research within the field of psychoneuroimmunology has highlighted significant 
variability in cortisol reactivity to stressors both across and within individuals depending upon 
stress paradigms, time or day, and other behavioral and health factors (Zänkert, Bellingrath, 
Wüst, & Kudielka, 2018). Further, some research has demonstrated that in contexts of stressors, 
cortisol levels may initially increase but decrease again to baseline once a stressor has been 
mastered, resulting in blunted reactivity patterns (Daruna 2012). This research is in line with 
more recent findings demonstrating that higher levels of reappraisal, or thinking differently about 
things when upset in order to change the emotional impact of certain thoughts, predicted stronger 
HPA habituation (e.g., more blunted cortisol responses) in response to stress compared to 
participants low in reappraisal abilities (Roos, Janson, Sturmbauer, Bennett, & Rohleder, 2019). 
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Taken together, these findings highlight importance in being able to change cortisol through 
experimental stressors as both increases and decreases in cortisol appear to be found within the 
literature. Future research should continue to examine what psychological processes may 
promote cortisol change and the specific processes implicated in the directionality of such 
changes given mixed findings overall.  
In terms of concordance, the hypothesis that cortisol, HRV, and inflammatory markers 
would covary across the different study conditions was not supported by these data. These 
findings are in contrast to some recent research that highlights experimentally induced cortisol 
responses being aligned with changes in c-reactive protein (CRP), a circulating protein in the 
body that is produced as a direct result of inflammatory release within the bloodstream (Laurent, 
Lucas, Pierce, Goetz, & Granger, 2016) and is often used as a marker of chronic inflammation. 
Interestingly, in the study by Lauren and colleagues (2016), the similarities in change between 
CRP and cortisol was strongest among participants with higher negative affect following a 
TSST, highlighting the unique role that negative emotional states may have in altering 
physiology. Recent research synthesizing findings that examine baseline correlations between 
different metrics of HRV and inflammation have shown some evidence for associations between 
these two biomarkers within single timepoints. Overall, researchers found that SDNN, one 
metric of HRV that represents both sympathetic nervous system and parasympathetic nervous 
system activity was most closely and consistently associated with inflammation (Williams, 
Koenig, Carnevali, Jarczok, Sternberg, & Thayer, 2019). Interestingly, given heterogeneity in 
types of experimental manipulations, the authors did not include any data associated with 
experimental change or change over time in this meta-analysis and it is therefore difficult to 
draw conclusions regarding whether these associations are maintained in the context of a 
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laboratory-based stressor such as the one utilized in the current study. Lastly, the exploratory 
hypothesis to examine if cortisol and/or HRV temporally preceded changes in inflammation 
throughout the study was not supported. Additionally, trait worry did not moderate this temporal 
relationship. These findings highlight that the faster-changing markers of HRV and cortisol did 
not necessarily change before inflammation across conditions. Given that not all biomarkers in 
the current study demonstrated significant changes across time, this finding was anticipated. 
However, similar to examining covariance among biomarkers, it does highlight interesting 
considerations for future research and our understanding of biomarkers and their interactions 
more broadly.  
Concordance among potential biomarkers is an important issue within the fields of 
clinical and health psychology, as it helps direct us towards the ways that physiological 
implications may be similar or different depending on the type of experimental stressor. Further, 
it is important to consider time course when examining concordance in experimental studies. 
Namely, given the relatively slow-changing nature of inflammation compared to HRV and 
cortisol, it may be that although there is not concordance between inflammation and these faster 
changing markers, it may not be anticipated when considering the biological composition of 
these different markers. While this finding was in contrast to the study hypotheses, it does 
highlight potential important implications for assessing biomarkers within both experimental and 
longitudinal designs and highlights the importance of using a multi-method approach to 
understand the impact of perseveration on physiology. Studies that only utilize a single marker 
(e.g., HRV) and determine that it is possible to change physiology experimentally may miss 
important information about other, slower-moving, physiological biomarkers have the potential 
to continue to worsen physical health over the long term.  
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Considerations and Future Directions 
An important strength of the current study is the utilization of multiple biomarkers within 
an idiographic experimental manipulation. Much of the previous research examining contrasting 
conditions such as these have focused on measuring a single biomarker or self-reported changes 
in purported cognitive and/or emotional mechanisms throughout the inductions. While this 
previous research offers important considerations, the utilization of a single biomarker fails to 
capture the intricacies of biology via targeting multiple systems within the body. Further, the 
utilization of contrasting conditions of worry and relaxation provide some insight into the ways 
in which physiology can be altered and subsequently improved through tasks aimed at inducing 
either worry or relaxation, respectively. Although further research is needed to help understand 
the nature and stability of these findings, the idea that physiology may be negatively altered via 
worry inductions and improved through relaxation training, even via short experimental 
manipulations is an important one in translating these basic findings to more applied research 
within clinical health psychology. Future research should attempt to build upon these findings to 
examine whether relaxation training delivered in brief formats may help to ameliorate short-term 
negative health implications for individuals with high degrees of trait worry. Further, it would be 
most beneficial for future research within this domain to follow participants longitudinally to 
examine whether the effects of brief relaxation trainings have physical health benefits over the 
long-term, as this is something that the current study was unable to assess. 
Although the use of multiple biomarkers is a strength of the current study and provides 
novel data not yet available in the field, there is a substantial degree of heterogeneity regarding 
how these data are collected within the field. The current study examined MSD as a metric of 
HRV which has been consistently utilized in research on emotion regulation and anxiety 
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(Applehans & Leukin, 2006) and has subsequently been shown to be associated with 
psychological symptoms and disorders, a number of other metrics, such as SDNN, may be more 
closely associated with inflammation and cortisol (Williams et al., 2019). In terms of cortisol 
collection, although this study utilized serum-derived cortisol, cortisol can also be assessed via 
saliva or hair samples. A previous meta-analysis has highlighted heterogeneity of data collection 
methods and analytical techniques for cortisol as one potential explanation for discrepancies 
between findings (Liu, Ein, Peck, Huang, Pruessner, & Vickers, 2017). Other findings have 
shown that cortisol in saliva is typically 10-35% lower than in the blood due to the 
transformation of cortisol as it enters into saliva (Vining, McGinley, Maksvytis, & Ho, 1983) 
although the two methods of collection correlate highly with one another. Overall, collection 
methods in the current study for all physiological outcome variables were consistent with 
previous research. However, an important step in better contextualizing these findings and others 
in the field is to establish best practices for collecting, analyzing, and interpreting these types of 
data.  
The experimental manipulations of worry and relaxation were based off of previous 
studies utilizing a similar design (Llera & Newman, 2010; Borkovec & Inz, 1990; Fisher & 
Newman, 2013). However, the conditions in the current study were significantly longer (10 
minutes) than those used in previous research. Findings indicated that this longer induction time 
appropriately and significantly increased both worry and relaxation during the respective 
conditions, highlighting that a longer duration of induction may be successful in experimental 
studies in addition to the previously utilized briefer designs. A 10-minute study design may be 
particularly beneficial for designs testing biomarkers such as inflammation that are relatively 
slow and less sensitive to experimental change, as a more salient and longer-lasting stressor may 
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be necessary to elicit immunological change in an experimental setting. However, previous 
studies utilizing this shorter duration of worry and relaxation inductions did not assess 
inflammation and it is therefore not possible to compare the findings from this study with 
findings from briefer designs. Further, previous studies utilizing these types of experimental 
inductions often randomized participants to undergo either a worry or relaxation induction rather 
than both, highlighting both a strength of the current study and potential limitation. The inclusion 
of both conditions in a fixed order in the current study allowed for examining the differential 
impact of worry and relaxation and the ways in which the body may “bounce back” 
physiologically after brief, relatively intense periods of worry. However, the inclusion of both 
conditions may have created a within-subject contamination effect, subsequently making it 
difficult to discern the impact of either condition in isolation. Future research may seek to 
expand upon the current study by utilizing a larger sample and randomizing participants to 
receive either worry or relaxation while simultaneously assessing changes in immune 
functioning before and after the inductions. 
Although the worry and relaxation manipulations were based off of previous research 
looking at stress inductions among individuals high in trait worry and diagnosed with GAD 
within the clinical psychology literature, other types of experimental stress inductions may be 
beneficial in altering inflammatory, endocrine, and cardiovascular reactivity. Clinical health 
psychology has most frequently utilized stressors comprised of social evaluative threat, and in 
particular the Trier Social Stress Test, to elicit experimentally induced endocrine change both in 
physically and psychologically healthy individuals (Dickerson & Kemeny, 2004) and those 
diagnosed with psychological disorders (Burke, Davis, Otte, & Mohr, 2005). Research on 
cortisol responsivity particularly has highlighted that biomarkers are sensitive to the types of 
IMMUNOLOGICAL AND PHYSIOLOGICAL IMPACT OF WORRY 
59 
 
stressors that are induced experimentally, and a stressor that activates on system within the body 
may not activate another (Baum & Grunberg, 1995). While social evaluative threat has been 
shown to be a salient stressor in evoking physiological change, these types of tasks may not be as 
salient for individuals who engage in high degrees of negative self-referential processing such as 
worry, rumination, and self-criticism (Mennin & Fresco, 2013) as their stressors become 
prolonged as a result of persistent thought patterns related to negative information about one’s 
self in their past, present, and anticipated future. Several other theories regarding physiological 
change have been proposed in terms of alterations as a result of experimental change. Along with 
social-evaluative threat and emotion inductions, cognitive tasks and tasks involving uncertainty 
may also be salient. Future research should attempt to further study methods that most strongly 
promote physiological change in different populations to better understand salient stressors. A 
paradigm such as the one used in the current study subsequently has the potential to help better 
understand the impact of such processes on health and highlight ways that stressors above and 
beyond social evaluative threat may alter physiology.  
An important consideration in this study is that it did not necessarily utilize individuals 
diagnosed with an anxiety disorder or other form of psychopathology, and rather relied on 
examining differences in high and low trait worry based on self-reported scores on the PSWQ. 
While this approach allowed me to examine a broader sample of individuals and there was a 
sufficient amount of variability in terms of PSWQ scores, stratifying based on high and low 
scores may have resulted in some participants in different groups looking more similar than 
different. Although study hypotheses adjusted for this in proposing that there would be no 
baseline differences between the two groups, it may be important for future research to more 
systematically examine differences among individuals high in trait worry in a way that may be 
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consistent with a diagnosis of GAD (e.g. PSWQ scores above 65; Meyer et al., 2000) and people 
with very low degrees of trait worry to better understand the differential impact of trait worry. 
The use of a PSWQ score of 56 was utilized to capture high worry that was not necessarily 
consistent with GAD, as splitting the current sample on the cut score of 65 resulted in 
substantially unequal groups (e.g., only 12 participants out of 85 with PSWQ > 65). 
Additionally, given that all participants commuted to the hospital where the clinic where the 
study took place was on the morning of the experiment, an additional consideration is that all 
participants, independent of group, may have experienced higher than average anticipatory 
anxiety at baseline that may have created a contamination effect in terms of the current findings. 
They may also have experienced higher baseline anxiety as a result of anticipation of the blood 
draw and interacting with the experimenter and nursing staff at the CTSC. The mean baseline 
WVAS rating across all participants was approximately 38 out of a possible 100, highlighting 
worry was present at a moderate level upon entering the clinic prior to undergoing any other 
experimental procedures.  
Although baseline state anxiety was not controlled for in these analyses, these findings do 
offer some insight into the ways that trait anxiety may dysregulate physiological functioning. 
While the findings examining changes across conditions for each biomarker was mixed, looking 
at high trait worry specifically highlights a dysregulated pattern of physiological responding, and 
offers several important considerations for future research. It may be worthwhile for future 
research to more specifically examine physiological changes for high trait worriers and look at 
within-subject changes rather than between-subject differences. Further, it is also important to 
also examine other potential trait-level variables that may impact physiological functioning, such 
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as trait anxiety or depression. This is an important next step in identifying how symptoms 
associated with psychopathology may impact endocrine, cardiovascular, and immune function. 
In addition to studying the ways that trait anxiety, depression, and other symptoms 
associated with psychopathology in differentially predicting trajectories of change in immune, 
endocrine, and cardiovascular function throughout the study, future research may benefit from 
examining the ways in which these physiological variables covary with psychological symptoms. 
Particularly, future research may benefit from examining whether subjective changes in worry 
and relaxation throughout experimental inductions covary with physical symptom changes. 
Further, it would be beneficial for these results to be better understood in the context of chronic 
stress literature within clinical health psychology. Chronic stress represents a consistent state of 
physiological activation and psychological stress due to uncontrollable or unpredictable stressors 
with no definitive endpoint, such as physical disabilities, caregiving, or having a low 
socioeconomic status (Baum, 1990). Chronic stress is associated with overall greater 
immunosuppression as well as increased levels of IL-6 and CRP (Segerstrom & Miller, 2004), 
highlighting a substantial negative impact of chronic stress on physical functioning. Indeed, both 
chronic stress and depression or anxiety may be somewhat related in their impact on 
inflammatory markers (Slavich & Irwin, 2014). However, experimental examinations of chronic 
stress and worry have not yet disentangled the unique contributions that perseverative processes 
such as worry may have on cardiovascular, endocrine, and immune function over and above 
chronic stress. Future research should therefore attempt to examine unique contributions of 
chronic stress and perseveration in exacerbating of maintaining physiological dysregulation. 
Further, it may be imperative to understand whether or not chronic stress moderates the impact 
of worry and other perseverative processes on physical functioning. If so, future research may 
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attempt to establish a better understanding of ways that this impact can be buffered through 
psychological interventions to target both stress and worry with the goal of reducing the 
likelihood of long-term negative health effects. 
An important next step in terms of research is to examine the physiological, cognitive, 
and behavioral mechanisms that may underlie the impact of worry on physical functioning. In 
response to anxiety and fear, the stress response is exacerbated among individuals with 
heightened emotions associated with anxiety disorders. The stress response may, in turn, 
promote a cascade of psychological and physiological processes, which is mediated by 
hypothalamic-pituitary-adrenal axis (HPA) dysregulation (Michopoulos et al., 2017). Through 
glucocorticoid insensitivity, HPA dysregulation is theorized to contribute to a state of low-grade 
inflammation, which might put an individual at risk for negative health consequences (Cohen, 
Janicki-Deverts, Doyle, Miller, Frank, Rabin, & Turner, 2012). Cognitive processes such as 
worry (McEvoy, Watson, Watkins, & Nathan, 2013), self-criticism (Sowislo & Orth, 2013), and 
intolerance of uncertainty (Carleton, 2012) may impact physiological responding, as these 
processes tend to prolong physiological activation through cognitive activation that is difficult to 
control. Finally, in terms of behavioral mediators, people who experience high degrees of worry 
and rumination may be less likely to engage in a healthy lifestyle. Notably, these individuals may 
be more likely to suffer from sleep disturbances, be less likely to engage in exercise, and may 
utilize alcohol, smoking, food, or drugs in an effort to regulate the negative emotions associated 
with these cognitive processes, subsequently putting them at risk for experiencing a number of 
poor health outcomes over the long term (Michopoulos et al., 2017; Pederson 2017). While the 
current study assessed whether or not people smoked, it did not assess a number of these other 
important health behaviors and therefore was not able to examine the impact of behavioral habits 
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on the physiological outcome variables of interest. Taken together, an essential avenue for future 
research is to take a more mechanistic approach to assessing the link between perseverative 
processes, such as worry, and physical health. Although worry may serve as one potential 
mechanism linking negative emotions to poor physical health, there may be other processes at 
play that may have the potential to exacerbate physiological dysregulation.  
Given the association between emotionality and increased physiological activation 
(Brosschot, Gerin, & Thayer, 2006), most recently I have begun to craft a theoretical model 
guided by the emotion dysregulation model of generalized anxiety (Mennin, Heimberg, Turk, & 
Fresco, 2005) and the PCH (Brosschot et al., 2006). The emotion dysregulation model, which 
highlights how primary and secondary emotions promote increases in perseverative processes 
such as worry, rumination, and self-criticism, has been used to guide an understanding of the 
ways that thoughts and emotions are connected in individuals experiencing chronic generalized 
anxiety. In comparison, the PCH highlights the ways that perseveration contributes to sustained 
physiological activation, putting an individual who experiences chronic worry and rumination at 
risk for long-term health issues. Overall, this new model posits the necessity of understanding the 
role that primary and secondary emotional responses have in prolonging cognitive and 
physiological activation and the central role that subsequent maladaptive emotion regulation 
strategies (both cognitive and behavioral) play in promoting poor physical health over the long 
term. An important assumption of this model is that secondary emotional responding (i.e., anger, 
sadness, and/or anxiety) promotes perseverative processes such as worry and rumination 
subsequently prolonging physiological activation via emotional and behavioral dysregulation. It 
therefore integrates past theories to link emotions, perseveration, and physiology. Future research 
should therefore attempt to better understand the impact of emotional functioning in the context 
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of perseverative thinking and physiological dysregulation. Negative emotions have been shown 
to promote the release of proinflammatory cytokines associated with numerous chronic illnesses 
(for a review, see Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002) but there has yet to be a 
comprehensive understanding of the ways that emotions interact with immune function to 
exacerbate or prolong physical health issues. Although this study provides one step in better 
testing this model, emotionality was not accounted for in analyses and future research may 
benefit from examining how emotion dysregulation may interact with perseveration to examine 
whether or not it contributes to increased physiological dysregulation.  
Given that the current study explicitly excluded participants who had medical conditions 
that are characterized by cardiovascular and immune dysregulation, it will also likely be 
important to expand upon this work to better understand these results in the context of 
individuals with chronic illnesses. Worry and rumination have been shown to be salient cognitive 
processes among several medical populations including cancer patients (Lampic, Wennberg, 
Schill, Brodin, Glimelius, & Sjödén, 1994; Berman et al., 2014) and survivors (Morris & 
Shakespeare-Finch, 2011). Given that findings from this study and others have highlighted some 
impact of worry on immune, cardiovascular, and endocrine function, it may be important for 
future research to better understand the ways in which perseverative processes such as worry and 
rumination may exacerbate or maintain some physiological dysregulation or pain experienced by 
these patients. Such an understanding would provide valuable insight into the ways in which we 
may be better able as a field to intervene on cognitive aspects of a person’s experience that may 
provide less suffering and impairment physically.  
While the inclusion of adult participants age 18-65 allowed this study to generalize more 
broadly to physically healthy adult populations, it is important to note that the physical health 
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profiles among participants of different age groups (e.g. emerging adults versus older adults) 
may influence inflammatory, endocrine, and cardiovascular function. Although age was 
appropriately examined as a potential covariate and older participants were no more likely to be 
on medication or be diagnosed with a medical condition than younger participants in the current 
study, there has been some research suggesting that health risk behaviors among adolescents and 
young adults may promote changes in physiological functioning later in adulthood (Cromwell, 
Puzia, & Yaptangco, 2015). It may therefore be important to disentangle the unique 
physiological profiles of different age groups in future research utilizing larger sample sizes or 
limiting the studies to more specific age ranges to better understand these nuances. Further, a 
number of studies specifically looking at cortisol responding and endocrine function limit 
samples to only male or female participants in order to control for hormonal differences. In order 
to increase both generalizability and feasibility, this was not done in the current study but may be 
an important direction for future research, particularly given that no research to date has 
examined sex differences in covariance of biomarkers or the impact of sex on differential 
inflammatory responding to experimental manipulations of stress and worry.  
Limitations 
 This study had several limitations which should be noted. First, given the contrasting 
conditions and length of time that previous studies have demonstrated is essential to demonstrate 
inflammatory change (Steptoe et al., 2007), it is difficult to disentangle whether inflammatory 
change following the relaxation induction was due exclusively to relaxation or whether a longer 
wait period was necessary following the worry condition. Along these lines, it is possible that the 
wait period for the blood draws following the worry and relaxation conditions were not long 
enough to detect a substantial change in inflammatory markers. Although a 30-minute wait 
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period was considered acceptable in a 2007 meta-analysis (Steptoe et al., 2007), resulted varied 
and overall found that longer wait periods following experimental manipulation (e.g., upwards of 
120 minutes) had higher effect sizes when examining inflammatory change compared to those 
studies that had briefer wait periods. Due to limitations in terms of space and compensation, we 
were unable to accommodate a longer wait period which may have subsequently impacted the 
current findings in relation to the inflammation data specifically. Additionally, participants were 
grouped based on their PSWQ scores as either ‘high’ or ‘low’ trait worry. However, as stated 
previously, these groups did not necessarily distinguish between individuals who had 
pathological levels of worry characteristic of GAD. Therefore, it is possible that breaking up the 
groups in this way may have resulted in non-severe worriers categorized as ‘high’ worry, and 
subsequently may not have high enough levels of worry to create a physiological distinction 
from the low trait worriers. Additionally, as discussed above, the environment where the 
experiment took place may have impacted worry and anxiety at baseline. In terms of 
experimental design, an additional limitation is that the current study was unable to follow 
participants across time, which may limit the generalizability of the current findings in 
identifying the impact that acute states of worry may have on physical health across time. 
Although previous research within this regard has yet to be conducted, it is reasonable to posit 
that should brief acute inductions of worry alter physiology, more chronic and pervasive 
episodes of worry in one’s everyday life outside of the laboratory are likely to create a larger 
‘sum’ of physiological dysregulation and subsequently increase the likelihood of an individual 
experiencing poor long-term health outcomes. 
Further, a number of potential covariates were assessed during the study that may have 
impacted physiological outcomes, including age, medication usage, gender, race, smoking status, 
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and BMI. However, there are several other variables that may impact these data, including sleep 
and exercise, which was not assessed in the current study. Previous research has demonstrated 
that sleep may have a significant impact on endocrine and immune functioning in healthy adults 
(Spiegel, Leproult, & Van Cauter, 1999). There has also been some evidence that vigorous levels 
of physical activity may decrease inflammation (Ford 2002). In contrast, moderate to high levels 
of physical activity has been shown to increase circulating cortisol levels in the blood (Hill, 
Zack, Battaglini, Viru, Viru, & Hackney, 2008). Given that amount, type, and frequency of 
physical activity in the morning before the experiment took place was not assessed it is not 
possible to determine its overall impact on the current findings. Among women, menstrual cycle 
is another potentially important covariate to consider (Kirschbaum, Kudielka, Gaab, Schommer, 
& Hellhammer, 1999) which was also not assessed in this study but may have important 
implications for cortisol output. Although this study did control for medication usage which 
included birth control, future research should take a more nuanced approach to these potential 
covariates and consider a broader array of factors that may impact physiological functioning. 
Given previous recommendations to further exclude participants based on a number of covariates 
shown to significantly influence immune functioning (O’Connor et al., 2009), future research 
may also attempt to further refine the inclusion criteria to account for these recommendations 
beyond what was done in the current study. Lastly, all of the outcome variables were non-normal 
prior to transformation based on the Shapiro-Wilk tests across all study conditions. While HRV 
was able to be normalized via a square root transformation, the cortisol and inflammatory data 
was not able to be normalized. Although parametric tests were utilized in order to examine 
hypotheses related to concordance, temporal spacing of biomarkers, and the group by condition 
interaction, these results should be interpreted with caution as the data violated assumptions 
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necessary to complete these analyses and interpret the findings with confidence. Data normality 
is a larger issue in the context of biomarkers, as data is most typically non-normal and there are 
no standards in terms of transforming variables to increase normality or conducting non-
parametric tests. It is therefore difficult to fully interpret these findings within the larger body of 
available research given that many studies do not report normality and whether or not data has 
been transformed prior to analysis.  
Conclusions 
 Despite these limitations, this study offers an ability to advance the field’s understanding 
of the differential impact of worry and relaxation on physiology independent of psychological 
disorders. To date, there has been no published findings of contrasting experimental conditions 
of worry and relaxation in exacerbating immune dysregulation. Such work is important in more 
fully examining how the processes associated with psychopathology may interact with 
biomarkers to influence physical health outcomes. Further, it highlights ways in which different 
physiological biomarkers may relate to one another which may provide important information 
for future research taking a multi-method approach to study the physical impact of worry and 
other perseverative processes. Overall, although additional research is needed, the current study 
provides some preliminary evidence that trait worry contributes to dysregulation of 
cardiovascular, endocrine, and immunological processes. An important next step from this study 
is to better examine the physiological processes linking worry and subsequent anxiety to chronic 
illnesses in an effort to better understand ways to intervene on this relationship. Further, a better 
understanding within these domains may have the potential to impact translational research and 
highlight avenues for future intervention work in ameliorating symptoms of worry and other 
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related processes and subsequently alter physiology and reduce the likelihood of developing 
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 M (SD) n % 
    
Baseline PSWQ 49.20 (14.7)   
Age 30.88 (11.4)   
% Female  53 62.4% 
Race    
White  31 39.2% 
African American  12 15.2% 
Asian American  19 24.1% 
Hispanic/Latino  12 15.2% 
Mixed Race  4 5/1% 
Other  1 1.3% 
% Students  46 57.5% 
% Employed  25 31.3% 
% Unemployed  9 11.3% 
BMI 24.76 (5.9)   
Note. M = mean, SD = standard deviation, % = percentage of participants, 

































Physiological Outcome Measure Correlations and Associated Covariates at Baseline 
Measure HRV IL-6 TNF-α IFN-γ Cortisol BMI Gender Age Medication Race Smoking 
HRV -           
IL-6 -.01 -          
TNF-α -.13 .36** -         
IFN-γ .03 .18 .40** -        
Cortisol .09 .12 -.04 .07 -       
BMI -.13 .34* .28** -.03 -.16 -      
Gender -.02 -.19 -.35** -.14
 
.08 -.50** -     
Age -.37** .33** .20 -.07 -1.0 .44** -.25* -    
Medication .13 .02 -.07 -.10 .22 -.01 .19 .00 -   
Race .06 -.05 .13 -.17 .04 .07 -.02 .04 .05 -  
Smoking .10 -.77** .07 -.82** -.01 -.03 .14 -.09 .07 .07 - 






Normality Tests for HRV 
 Statistic df Sig. 
Baseline    
Non-transformed .937 71 .001 
Lg-10 transformation .953 71 .010 
Sqrt transformation .987 71 .695 
Worry    
Non-transformed .928 71 .001 
Lg-10 transformation .946 71 .004 
Sqrt transformation .976 71 .195 
Relaxation    
Non-transformed .963 71 .037 
Lg-10 transformation .936 71 .001 
Sqrt transformation .988 71 .727 
Note. HRV = heart rate variability; Lg-10 = log10; sqrt = square root; df = degrees of freedom; 

































Normality Tests for Cortisol 
 Statistic df Sig. 
Baseline    
Non-transformed .890 77 .000 
Lg-10 transformation .982 77 .333 
Sqrt transformation .948 77 .003 
Worry    
Non-transformed .882 77 .000 
Lg-10 transformation .981 77 .318 
Sqrt transformation .943 77 .002 
Relaxation    
Non-transformed .830 77 .000 
Lg-10 transformation .964 77 .026 
Sqrt transformation .909 77 .000 


































Normality Tests for IL-6 
 Statistic df Sig. 
Baseline    
Non-transformed .875 78 .000 
Lg-10 transformation .967 78 .032 
Sqrt transformation .944 78 .002 
Worry    
Non-transformed .771 78 .000 
Lg-10 transformation .978 78 .209 
Sqrt transformation .914 78 .000 
Relaxation    
Non-transformed .903 78 .000 
Lg-10 transformation .992 78 .928 
Sqrt transformation .971 78 .076 


































Normality Tests for TNF-α  
 Statistic df Sig. 
Baseline    
Non-transformed .974 78 .115 
Lg-10 transformation .993 78 .950 
Sqrt transformation .992 78 .897 
Worry    
Non-transformed .494 78 .000 
Lg-10 transformation .861 78 .000 
Sqrt transformation .690 78 .000 
Relaxation    
Non-transformed .561 78 .000 
Lg-10 transformation .915 78 .000 
Sqrt transformation .769 78 .000 
Note. TNF-α = tumor necrosis factor-alpha; Lg-10 = log10; sqrt = square root; df = degrees of 

































Normality Tests for IFN-γ  
 Statistic df Sig. 
Baseline    
Non-transformed .879 78 .000 
Lg-10 transformation .987 78 .627 
Sqrt transformation .953 78 .006 
Worry    
Non-transformed .803 78 .000 
Lg-10 transformation .979 78 .221 
Sqrt transformation .913 78 .000 
Relaxation    
Non-transformed .494 78 .000 
Lg-10 transformation .953 78 .007 
Sqrt transformation .772 78 .000 
Note. IFN-γ = interferon gamma; Lg-10 = log10; sqrt = square root; df = degrees of freedom; sig 





























Paired Sample t-Test Results Comparing Experimental Inductions 
 Experimental Inductions Paired Differences 95% CI  





Baseline WVAS Rating 
Post Worry Task WVAS 
 
Baseline RelaxVAS Rating  
Post Relaxation Task RelaxVAS 
 
Baseline WVAS Rating 
Post Relaxation Task WVAS 
 
Baseline RelaxVAS Rating 













































































Note. WVAS = Worry Visual Analogue Scale; RelaxVAS = Relaxation Visual Analogue Scale, M = mean; SD = standard deviation; 








Means and Standard Deviations of Outcome Variables 





















Note. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = interferon gamma; 




Means and Standard Deviations of Outcome Variables by Group 
 Baseline Worry Relaxation 
HRV    
Low PSWQ 31.62 (18.6) 30.03 (16.2) 35.28 (16.5) 
High PSWQ 33.69 (13.9) 30.25 (9.1) 38.52 (16.1) 
Cortisol    
Low PSWQ 14.90 (6.5) 13.42 (5.9) 12.59 (6.1) 
High PSWQ 14.57 (6.2) 13.10 (5.6) 12.33 (5.2) 
IL-6    
Low PSWQ .46 (0.2) .48 (0.2) .56 (0.3) 
High PSWQ .42 (0.3) .50 (0.4) .58 (0.4) 
TNF-α    
Low PSWQ 1.81 (0.6) 1.80 (0.5) 1.80 (0.6) 
High PSWQ 1.84 (0.4) 2.24 (1.7) 2.04 (1.3) 
IFN-γ    
Low PSWQ 4.46 (2.6) 4.20 (2.4) 4.10 (2.4) 
High PSWQ 3.77 (2.0) 4.16 (3.4) 4.32 (5.9) 
Note. HRV = heart rate variability; IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; 































Correlations Between Outcome Variables at Baseline 
Measure HRV IL-6 TNF-α IFN-γ Cortisol 
HRV -     
IL-6 -.01 -    
TNF-α -.13 .36** -   
IFN-γ .03 .18 .40** -  
Cortisol .09 .12 -.04 .07 - 
Note. **p < .01, *p < .05. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = 





Correlations Between Outcome Variables After Worry Condition 
Measure HRV IL-6 TNF-α IFN-γ Cortisol 
HRV -     
IL-6 -.04 -    
TNF-α -.09 .68** -   
IFN-γ .03 .41** .65** -  
Cortisol .04 -.16 -.17 -.10 - 
Note. **p < .01, *p < .05. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = 




Correlations Between Outcome Variables Following Relaxation Condition 
Measure HRV IL-6 TNF-α IFN-γ Cortisol 
HRV -     
IL-6 -.22 -    
TNF-α -.29* .47** -   
IFN-γ -.30* .37** .84** -  
Cortisol .02 -.13 -.09 -.08 - 
Note. **p < .01, *p < .05. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = 




Covariance of outcome variables across conditions 
Measure F df 95% CI p-value Cohen’s d 
IL-6, HRV, & Cortisol 1.51 170.75 -.01 - .003 .22 .27 
TNF-α, HRV, & Cortisol .008 109.52 -.02 - .02 .93 .02 
IFN-γ, HRV, & Cortisol 1.80 115.95 -.02 - .10 .18 .30 
HRV & Cortisol 1.17 148.72 -.01 - .04 .28 .24 
Note. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = interferon gamma; 








































Figure 1.  
Means of WVAS and RelaxVAS throughout experiment 
 
 
Note. WVAS = Worry Visual Analogue Scale; RelaxVAS = Relaxation Visual Analogue Scale. 
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